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Abstract 
 
This thesis details my examination of several mechanisms for modulation of 
neuropeptide release via voltage-dependent and voltage-independent intraterminal 
signaling in isolated neurohypophysial terminals. The first part of this work characterizes 
depolarization-induced neuropeptide release in the absence of extracellular calcium. The 
goal of this project was to examine the relationship between depolarization-induced 
release of intracellular calcium stores and depolarization-secretion coupling of 
neuropeptides. We demonstrate that depolarization in the absence of extracellular 
calcium induced by either High K+ or electrical stimulation induces a rise in [Ca2+]i and 
subsequent neuropeptide release from Hypothalamic Neurohypophysial System (HNS) 
terminals. A portion of extracellular calcium-independent neuropeptide release is due to 
intraterminal calcium, but the remaining depolarization-induced release may be due to 
calcium-independent voltage-dependent (CIVD) release (Zhang and Zhou, 2002; Zhang 
et al., 2004; Yang et al., 2005). Nevertheless, our results clearly show that extracellular 
calcium is not necessary for depolarization-induced neuropeptide secretion from these 
CNS terminals. 
In addition, I investigated the role of internal calcium stores in mediating μ-opioid 
inhibition of voltage-gated calcium channels (VGCCs). Inhibition of VGCCs via μ-
opioid agonists has been shown to reduce neuropeptide release in response to High K+ 
stimulation of isolated terminals (Bicknell et al., 1985b; Russell et al., 1993; van 
Wimersma Greidanus and van de Heijning, 1993; Munro et al., 1994; Ortiz-Miranda et 
al., 2003; Russell et al., 2003; Ortiz-Miranda et al., 2005).  My findings show μ-opioid 
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inhibition, of VGCC and High K+-mediated rise in [Ca2+]i, are via a voltage-independent 
diffusible second-messenger targeting release of calcium from ryanodine-sensitive stores, 
possibly mediated via the cyclic ADP ribose signaling pathway.  
Furthermore, I detail a different intracellular messenger pathway mediating the κ-
opioid inhibition of VGCC and High K+-mediated rise in [Ca2+]i. In contrast to the μ-
opioid inhibition, κ-receptor activation is coupled to a voltage-dependent membrane-
delimited pathway. Inhibition of neuropeptide release via both endogenous and 
exogenous κ-opioid agonists has been extensively studied (Bicknell et al., 1985a; 
Nordmann et al., 1986a; Wammack and Racke, 1988; Munro et al., 1994; Ingram et al., 
1996; Rusin et al., 1997a). My investigation shows that the κ-inhibition of VGCC is 
voltage-dependent and is furthermore, relieved within the context of a physiological burst 
of action potentials (APs). This physiologically-evoked, activity-dependent modulation of 
VGCC and subsequent release, represents an important mechanism for short-term 
synaptic plasticity at the level of the terminals. Given the ubiquitous nature of voltage-
dependent G-protein signaling in the CNS, our results may prove important in 
understanding modulatory effects of specific bursting patterns throughout the CNS. 
In the last 30 years the neurohypophysial system has proven to be an excellent system to 
study the complexities of depolarization-secretion coupling (DSC). There have been 
many advances in our understanding of the underlying mechanisms involved and their 
physiological implications. The current work focuses on two important features of DSC; 
voltage and calcium. Although in many ways these two are intrinsically linked through 
VGCC activation, we have found that in isolated HNS terminals that is not always the 
case. We have further found that when voltage and calcium influx are linked during DSC, 
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modulation by opioids may or may not be linked to activity-dependent relief depending 
on the opioid receptor activated.  This finding has important implications in neuropeptide 
release during patterned stimulation in vivo. As I will discuss further, many factors play 
into the complexities of the regulatory mechanisms involving release. As investigations 
into this remarkable field continue, I hope to have contributed a valuable piece to the 
puzzle. 
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Chapter I 
 
 
 
Introduction 
 
 
 
Hypothalamic Neurohypophysial system 
 Magnocellular neurosecretory cells (MNC) project axons to the neurohypophysis 
where both oxytocin (OT) and arginine vasopressin (AVP) are released for systemic 
circulation. Oxytocin (OT) has been shown to be important during parturition and 
essential for milk-let down during lactation in females, in males it stimulates contractions 
of the reproductive tract aiding sperm ejaculation (Insel, 1992; Russell et al., 2003; Leng 
et al., 2005; Thackare et al., 2006) (Fig. 1.1). OT also has an emerging role as a 
natriuretic agent (Lemos et al., 2002). Behavioral studies have shown the role of oxytocin 
(OT) in modulating stress, pair-bond formation, parental behavior, social recognition, and 
important aspects of attachment (Insel, 1992; Zingg, 1996; Choleris et al., 2003; Razzoli 
et al., 2003; Bartz and McInnes, 2007; Jin et al., 2007; Campbell, 2008). Arginine 
vasopressin (AVP) plays a vital role in systemic sodium and water homeostasis as an 
antidiuretic (Gruber and Eskridge, 1986; Bourque and Oliet, 1997), it is also a potent 
vasoconstrictor (Altura and Altura, 1977; Russ et al., 1992) and, like OT, has a role in 
affiliation behaviors (Lohmeier, 2003; Caldwell et al., 2008). Various endogenous 
excitatory and inhibitory inputs project onto the magnocellular neurosecretory system at 
various levels affecting release of both oxytocin and vasopressin. Autocrine and paracrine 
effects of AVP at the dendrites and cell bodies have shown activity-dependent 
modulation (Niermann et al., 2001; Mueller et al., 2005; Bull et al., 2006; Brown et al., 
2007). Other compounds co-released with both neuropeptides also exert modulatory 
effects on somatodendritc excitability such as; ATP (Troadec and Thirion, 2002; Bull et 
al., 2006), and endogenous opioids (Leng et al., 1985; Brown et al., 2007). At the 
terminals, characteristic electrical input from OT and AVP cell bodies is associated with 
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optimum excitation-secretion coupling of their specific neurohormones. OT neurons are 
characterized by a high-frequency discharge, which occurs during suckling, triggering 
pulsatile release of OT, while AVP neurons are characterized by their asynchronous 
phasic activity (bursting) during maintained AVP release (Armstrong and Sladek, 1982; 
Poulain and Wakerly, 1982; Andrew and Dudek, 1983). Autocrine and paracrine 
modulation by AVP and OT seems unlikely at the Neurohypophysis given there are no 
known OT receptors in the terminals and the presence of AVP receptors is still debated 
(Dashwood and Robinson, 1988; Hatton et al., 1992). However, substances co-released 
with either/or AVP and OT, such as endogenous opioids (Iversen et al., 1980; Lightman 
et al., 1983; Bicknell et al., 1985b; Nordmann et al., 1986b; Bicknell et al., 1988; Zhao et 
al., 1988a; Sumner et al., 1990; Leng et al., 1994; Ortiz-Miranda et al., 2003), and ATP 
(Lemos and Wang, 2000a; Sladek and Kapoor, 2001; Troadec and Thirion, 2002; Wang 
et al., 2002a; Knott et al., 2005; Song and Sladek, 2005; Knott et al., 2007) are known to 
have significant modulatory effects on VGCC and DSC. The intraterminal mechanisms 
mediating these effects on VGCC and subsequent stimulus-secretion coupling are yet to 
be understood.  
 
Patterns of electrical stimulation inducing optimum neuropeptide release 
 As mentioned above, the optimum firing pattern for eliciting AVP and OT release 
are different (Fig. 1.2). Optimum AVP release is stimulated by an asynchronous phasic 
bursting with periods of firing and silence from 20-40 sec. with and average mean 
frequency of 10-20 Hz (Wakerley et al., 1978; Armstrong and Sladek, 1982; Cazalis et 
al., 1985; Gainer et al., 1986; Richard et al., 1997). OT discharge is preceded by a high 
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frequency burst pattern approx. 10-77 Hz for 0.9-4.7 sec. with a burst latency of 13.3 sec. 
(Lincoln and Wakerley, 1974; Armstrong and Sladek, 1982; Poulain and Wakerly, 1982; 
Andrew and Dudek, 1983).  Research exploring the possible mechanisms that connect the 
burst patterning to optimal release have been ongoing. Starting in 1971, action potentials 
were determined to be the mechanisms via which electrical impulses were transmitted 
from magnocellular neurons to the Neurohypophysis eliciting neuropeptide release 
(Dreifuss et al., 1971). These studies showed for the first time, that the total number of 
stimuli applied and the frequency of stimulation were both important for optimum 
release. Future studies confirmed these findings and further found other important 
parameters for eliciting release such as burst frequency, AP broadening, burst duration 
and interburst interval (Dutton and Dyball, 1979; Shaw et al., 1984; Jackson et al., 1991b; 
Seward et al., 1995). In the neurohypophysis, as in other systems, action potentials 
undergo a gradual broadening when elicited repetitively. The degree and rate of 
broadening is dependent on firing frequency (Gainer et al., 1986; Bourque, 1990; Jackson 
et al., 1991b). It was first believed that the phenomenon of AP broadening, which leads to 
an increased rise in [Ca2+]i per AP, was responsible for neuropeptide release facilitation in 
response to higher frequency stimulation. However, this could not be the complete 
answer, given that parameters for maximal broadening at the somata did not correlate 
with firing rates evoking maximal release from HNS terminals (Andrew, 1986; Jackson 
et al., 1991b). Furthermore, after eliminating frequency dependent changes in AP 
duration there was still a residual frequency dependent rise in [Ca2+]i (Jackson et al., 
1991b). Other considerations, such as axonal cable properties (Nordmann and Stuenkel, 
1986), changes in [K+]o  accompanying high-frequency stimulation (Leng et al., 1988a), 
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and endogenous opioid modulation (Bicknell, 1988; Bondy et al., 1988; Wammack and 
Racke, 1988) emerged as important factors in the efficiency of patterned stimulation in 
vivo. Studies done in the intact Neurohypophysis further showed that known intrinsic 
changes in intrerstitial concentrations of calcium and potassium during action potential 
activity, modulate biophysical properties of voltage-gated channels contributing to 
frequency-dependent facilitation of neuropeptide release (Marrero and Lemos, 2005).  It 
is now known that activity-dependent changes, play a vital role in translating electrical 
activity to individual terminals and modulate the spatial spread of excitation within a 
field of HNS axons (Bourque, 1991; Marrero and Lemos, 2005; Bull et al., 2006).  The 
activation of VGCC during action potential activity represents an important link in 
establishing a connection between stimulus and secretion. Therefore, one of the aims of 
my current work is to understand the activity-dependent modulation of VGCC via opioid 
receptor activation in isolated HNS terminals. 
 
Intraterminal Ca2+ stores in the Neurohypophysis  
 Initial studies of the role of internal calcium stores in isolated Neurohypophysial 
terminals during DSC were controversial (Salzberg et al., 1985; Stuenkel, 1991, 1994). 
The lack of documented effects of either caffeine or ryanodine on depolarization-induced 
release (Stuenkel, 1994) suggested there were no ryanodine-sensitive stores present in the 
Neurohypophysial terminals. However recently, spontaneous small ryanodine-sensitive 
Ca2+ release events from isolated terminals have been characterized (De Crescenzo et al., 
2004b; De Crescenzo et al., 2006). The spontaneous Ca2+ release events were termed 
syntillas, and are both ryanodine- and voltage-sensitive. Syntillas result from the 
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activation of both RyR type-1 and type-2. Presumably, the type-1 RyR confers the 
voltage-sensitivity via direct interaction with VGCC, as documented in the skeletal 
muscle (De Crescenzo et al., 2006). Similar spontaneous release events were later 
discovered in chromaffin cells with similar ryanodine sensitivity although no voltage-
dependence (ZhuGe et al., 2006). Interestingly there is only RyR type-2 and type-3 in 
chromaffin cells, supporting the hypothesis that type-1 RyR in the neurohypophysial 
terminals are linked to voltage-dependence. Both of these subclasses of ryanodine 
receptors may act on distinct pools of calcium stores in terminals modulating 
intraterminal Ca2+-sensitive processes in distinct spatio/temporal configurations triggered 
by Ca2+, cADPr, and/or voltage. Ongoing studies suggest that these ryanodine receptors 
are located in the granules and are involved in DSC modulation (McNally et al., 2006; 
2007).  
 Other HNS intraterminal stores are also present such as, the inositol- 1,4,5-
trisphosphate (IP3) calcium stores (Sabatier et al., 2004; Ludwig and Leng, 2006; Leng et 
al., 2008). Studies on isolated HNS permeabilized terminals, treatment with IP3 induced a 
242% rise above baseline AVP release (Cazalis et al., 1987a) indicating IP3 stores not 
only exist in terminals but are capable of participating in release. Immunogold labeling 
with electromagnetic imaging (EM) has confirmed the existence of IP3 receptors in HNS 
terminals (B. Salzberg personal communication). In magnocellular oxytocin neurons, IP3 
stores have been further shown to contribute to OT release in the absence of extracellular 
calcium (Richard et al., 1997). Both ryanodine and IP3 intraterminal calcium stores pose 
interesting questions regarding their physiological role during DSC, which is currently 
the focus of intense research.  
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 On the other side of the intraterminal calcium equation, several calcium extrusion 
mechanisms exist to regulate [Ca2+]i (Fig. 1.3). Regulating changes in intraterminal 
calcium due to either calcium release from stores or calcium influx, are endogenous 
buffering mechanisms such as intracellular Ca2+ binding proteins (Stuenkel, 1994), Ca2+ 
extrusion through the Ca2+ pump in the plasma membrane (Sasaki et al., 2005), Ca2+ 
uptake by mitochondria (Stuenkel, 1994; Sasaki et al., 2005) and K+-dependent Na+/Ca2+ 
exchanger (Lee et al., 2002). Therefore, as in other systems, HNS intraterminal calcium is 
tightly regulated due to its important role in eliciting and modulating DSC. 
 
Ca2+ channels contributing to neuropeptide release from isolated terminals 
 Initial characterization of the L-type voltage-gated calcium channel (VGCC) in 
isolated terminals was first published in 1989 (Lemos and Nowycky, 1989a). Studies on 
neuropeptide release in response to a depolarizing stimulus had already demonstrated the 
importance of VGCC during DSC (Nordmann et al., 1982; Dayanithi et al., 1988). 
Further research on the characterization of VGCC in isolated terminals found the 
presence of N-type, P/Q-type and R-type in the Neurohypophysis (Dayanithi et al., 1988; 
Salzberg and Obaid, 1988; Lemos and Nowycky, 1989b; Obaid et al., 1989; Fatatis et al., 
1992; Wang et al., 1993b; Wang et al., 1999a). Interestingly, OT containing terminals 
express L-, N-, and R-type VGCC while AVP containing terminals express L-, N-, and 
Q-type VGCC (Wang et al., 1991, 1992; Wang et al., 1997a; Wang et al., 1999b).  
 The relative contributions of each VGCC to release of either OT or AVP were 
measured in response to High K+-induced release of neuropeptide and analyzed with a 
radioimmunoassay (Wang et al., 1997a; Wang et al., 1999b). Results showed approx. 
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59% of either OT or AVP release was via activation of the L- and N-type calcium 
channel, Q-type represented approx 24% of AVP release and R-type approx. 35 % of OT 
release.  Interestingly, in these studies there was a component of High K+-induced release 
that was not blocked by any of the VGCC blockers. 
 
 
G-protein modulation of calcium channels 
 Regulation of VGCC by G-proteins (guanine nucleotide-binding proteins) begins 
with the activation of G-protein coupled receptors (GPCR). GPCRs interact with G-
proteins, which are membrane-associated proteins, composed of three subunits, α, β, and 
γ. Activation of the GPCR leads to a conformational change in the G-protein resulting in 
two important events. First, the Gα subunit exchanges GDP for GTP, followed by the 
dissociation of the Gα with the βγ-subunits. Both the Gα-GTP and the Gβγ are active 
signaling complexes with several possible downstream effectors.  G-protein signaling is 
terminated by the intrinsic alpha-subunit GTPase activity, catalyzing the hydrolysis of 
bound GTP to GDP + Pi. This is accelerated in situ by regulators of G-protein signaling 
(RGS) proteins, acting as GTPase-activating proteins (GAPs). Hydrolysis of the GTP 
promotes the reassembly of the inactive Gα-GDP and Gβγ trimer.  
 Several different subtypes of α, β, and γ subunits can form each of the G-protein 
trimers. More than twenty Gα subunits have been identified in mammalian systems 
(Offermanns et al., 1997). These are classified into five groups according to their 
downstream effectors (Tedford and Zamponi, 2006). Activation of adynylyl cyclase is 
targeted by Gαs and inhibition is mediated by Gαi, which include Gαo and Gαz (McCudden 
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et al., 2005). The Gαq is associated to activation of phospholipase Cβ (Rhee, 2001). The 
Gβ subunits have five known subtypes and twelve subtypes for the Gγ (Davies, 2002; 
Tedford and Zamponi, 2006). Differences in subtypes can be genetic or post-translational 
modifications resulting in >1,000 possible combinations of Gα, Gβ, and Gγ trimers.  
However, constraints on cellular and subcellular expression, as well as, thermodynamic 
binding compatibility limit the number of heterotrimeric complexes that actually exist 
(Connor and Christie, 1999; Davies, 2002; Tedford and Zamponi, 2006).  
 Trimeric G-proteins primarily involved in the modulation of voltage-gated 
calcium channels are composed of Gαi, Gαo, or Gαq (Brown and Sihra, 2008). Inhibitory 
effects have been reported to mediate the presynaptic inhibitory effects on VGCC of 
many neurotransmitters such as muscarinic receptors (Brody et al., 1997; Brody and Yue, 
2000), adrenoreceptors (McFadzean et al., 1989; Silinsky, 2004), opioid receptors (Rusin 
and Moises, 1995; Rusin et al., 1997b; Ortiz-Miranda et al., 2003), and GABAB 
receptors (Pfrieger et al., 1994). The Gα(i/o) βγ-associated subunits ubiquitously act via 
direct binding to VGCC known as a voltage-dependent membrane-delimited pathway, 
resulting in a shift in gating kinetics from “willing” to “reluctant” and thus, reduced Ca2+ 
influx during DSC (Fig. 1.4). The G-protein voltage-dependent inhibition of VGCC can 
be reversed by strong membrane depolarizations triggering dissociation of the Gβγ 
subunits from the VGCC, thus relieving inhibition of the current. Different Gβγ subunit 
complexes have been studied to quantify their ability to mediate this type of voltage-
dependent inhibition on specific types of VGCC (Garcia et al., 1998; Arnot et al., 2000; 
Ruiz-Velasco and Ikeda, 2000). These studies show a range of complex inhibitory 
interactions between the Gβγ subunit complexes and VGCC, which strongly depend on 
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experimental conditions. However, results suggest N-type voltage-dependent inhibition is 
best mediated by the Gβ1γ2 and Gβ3γ2 complexes and the P/Q-type by the Gβ4γ2 (Arnot et 
al., 2000). The Gαq has been reported to inhibit VGCC through activation of target 
diffusible second-messenger pathways (phospholipase-C PLC, and adenylate cyclase, 
AC) by the GTP-bound α-subunits (Aantaa et al., 1995; Zhou et al., 2007; Brown and 
Sihra, 2008). This type of inhibition cannot be reversed by strong membrane 
depolarizations and is thus referred to as voltage-independent G-protein modulation. 
Membrane-delimited voltage-dependent pathways and diffusible second messenger, 
voltage-independent pathways, are not mutually exclusive. For example, the muscarinic 
M1 (Meza et al., 1999; Kammermeier et al., 2000) and neurokinin 1 (Meza et al., 2007) 
receptors both inhibit the N-type VGCC via a voltage-independent Gαq mediated pathway 
concurrent with Gβγ membrane-delimited voltage-dependent interaction. Many factors 
contribute to the overall complexity of GPCR signaling. The signaling complexities 
expand the possibilities for modulation tailoring calcium influx in response to a particular 
physiological context. This results in an orchestrated response for optimum neuropeptide 
release. 
 
Mechanisms of G-protein mediated opioid effects 
 Opioid receptors are part of the G-protein coupled receptor (GPCR) family I 
subfamily IV (Davies, 2002). This classification is based on similarities within the GPCR 
amino acid sequence and the chemical nature of their ligands as determined by molecular 
cloning studies and genome data analysis. The three main types of opioid receptors (using 
the classic Greek nomenclature) are μ, κ and δ. A fourth opioid receptor (opioid receptor 
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like 1), with over 60% homology with the three previously cloned opioid receptors, has 
also been isolated (New and Wong, 2002). ORL1 is activated by nociceptin, however, it 
has a very different pharmacological profile than the other three receptors. The IUPHAR 
Nomenclature Committee has formally renamed opioid receptors μOP or MOP, δOP or 
DOP and κOP or KOP, and NOP (for ORL1), OP standing for opioid peptide family, 
although the classic Greek nomenclature for the three main receptors is still extensively 
used (Dhawan et al., 1996; Davies, 2002).  
 Opioid receptors have been found all over the peripheral and central nervous 
system and most notably modulate behaviors such as, stress, pain, reward and motivation 
(Anton, 1996; Zadina et al., 1999; Fricchione and Stefano, 2005; Fichna et al., 2007) 
amongst others. They are activated by several endogenous opioid agonists derived from 
proopiomelanocortin, proenkephalin and prodynorphin (Davies, 2002). Like other 
GPCRs, opioid receptors mediate receptor signaling via activation of heterotrimeric G-
proteins. They are all capable of interacting with the pertussis toxin-sensitive G-protein 
alpha-subunits Gαi1, Gαi2, Gαi3, Gαo1, Gαo2 and the pertussis toxin-insensitive Gαz and Gα16 
(Connor and Christie, 1999; Brown and Sihra, 2008).  The predominant effector pathway 
being inhibition of adenylyl cyclase through pertussis toxin-sensitive G-proteins, most 
likely of the Gαi/Gαo class coupled to inwardly rectifying K+ channels or voltage-gated 
Ca2+ channels (North and Williams, 1985; Piros et al., 1996; Hawes et al., 2000). It is 
generally accepted that interaction between any given opioid receptor and its effector is 
dictated more by availability of G-protein subtypes within the cell or presynaptic site, 
rather than the requirement for a specific coupling between an opioid receptor and G-
protein subtype.  
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 G-protein targeting of ionic currents involved in modulation of neurotransmitter 
release are primarily of the Go, Gq, and Gs subtypes (Brown and Sihra, 2008). The Gs 
alpha subunit is not known to mediate any opioid receptor effects unlike the Go and Gq. 
These alpha G-proteins are further associated with their respective β, γ subunits. The β, γ 
subunits can directly associate to the voltage-gated Ca2+ channel alpha1 pore forming 
complex, resulting in a gating mode shift from “willing” to “reluctant” resulting in the 
reduction of Ca2+ influx through the channel. This is also known as voltage-dependent 
inhibition mediated by a membrane-delimited signaling pathway (Zamponi and Snutch, 
1998; Endoh, 2004; Brown and Sihra, 2008). 
 Furthermore, opioid receptor activation of G-proteins can initiate intracellular 
signaling cascades involving diffusible second-messengers such as, adenylyl cyclase 
(Meng et al., 1993; Fukuda et al., 1994; Piros et al., 1995; Law et al., 2000; Kaminski, 
2004), phospholipase C (Johnson et al., 1994; Spencer et al., 1997; Law et al., 2000; 
Kaminski, 2004), and mitogen-activated protein kinases ERK1 and ERK2 (Fukuda et al., 
1996; Li and Chang, 1996; Law et al., 2000; Kim et al., 2006). Mobilization of internal 
calcium in response to activation of opioid receptors has been well documented in both 
neuronal and non-neuronal systems (for review; Samways and Henderson, 2006). 
Typically a rise in  [Ca2+]i results from the activation of a Gαq-coupled opioid receptor 
activating an inositol phosphate signaling pathway leading to release of [Ca2+]i from IP3 
stores. Ryanodine-sensitive calcium stores have also been shown to be targets of G-
protein opioid activation. Although the mechanism is not known, evidence suggests it is 
either via a calcium-induced calcium release mechanism (CICR), as a secondary effect of 
release from IP3 stores, or through activation of the cyclic ADP ribose (cADPR) signaling 
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pathway. For example, activation of the μ-opioid receptor in isolated mouse astrocytes 
elicited a release of [Ca2+]i blocked by the ryanodine–sensitive antagonist, dantrolene 
(Hauser et al., 1996). In isolated rat ventricular myocytes the rise in [Ca2+]i due to κ-
receptor activation was blocked when ryanodine-sensitive stores were depleted with 
ryanodine pretreatment (Tai et al., 1992). Opioid receptor-mediated elevations of [Ca2+]i 
may target multiple Ca2+-dependent processes important in modulating vesicular 
mobilization, priming and/or exocytosis during stimulus-evoked release. Currently, we 
are proposing a diffusible second messenger pathway for the μ-opioid receptor activation 
in isolated terminals of the Neurohypophysis, initiating release of intraterminal Ca2+ from 
ryanodine-sensitive stores via cyclic ADP ribose (cADPR) signaling pathway mediating 
the inhibition of VGCC and subsequent release (Fig.1.5).  
 
Opioid modulation of VGCC in Hypothalamic Neurohypophysial system 
 In the Neurohypophysis, like in other systems, Ca2+ influx though activation of 
presynaptic high threshold voltage-gated calcium channels is essential to induce large 
bulk neuropeptide release (Cazalis et al., 1987b; Giovannucci and Stuenkel, 1997; Wang 
et al., 1997a; Wang et al., 1999b). Endogenous opioid inputs to the magnocellular 
neurosecretory system (See Fig. 1.6) which potentially target VGCC include enkephalins 
from the pars intermedia (Rossier et al., 1980), endomorphin from the arcuate nucleus 
(Chen et al., 2004; Hui et al., 2006), met-enkephalin and dynorphin A, co-released with 
OT and AVP respectively (Bondy et al., 1988; Leng et al., 1994). Studies showed that in 
the HNS, both AVP and OT are inhibited during electrically stimulated release by opioid 
agonists (Clarke et al., 1979; Bicknell and Leng, 1981; Clarke et al., 1981; Bicknell et al., 
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1985b; Nordmann et al., 1986a; Bondy et al., 1988). Furthermore, a pure preparation of 
isolated terminals from the Neurohypophysis also showed a reduction in depolarization-
induced release of both OT and AVP in response to both μ- (Zhao et al., 1988b; Leng et 
al., 1992; Russell et al., 1995a; Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005) 
and κ-opioid (Bicknell et al., 1988; Bondy et al., 1988; Zhao et al., 1988a; Rusin et al., 
1997b) receptor activation. This strongly suggests that opioid inhibition of neuropeptide 
release is acting directly on the terminal receptors and not on surrounding pituicytes 
(Zhao et al., 1988c). This inhibition has been shown to target specifically, high-threshold 
voltage-gated calcium channels (Rusin et al., 1997b; Ortiz-Miranda et al., 2003; Ortiz-
Miranda et al., 2005). Unlike μ-opioid inhibition, κ-inhibition may target both OT and 
AVP release differently depending on the specific κ-receptor agonist (Zhao et al., 1988a). 
A mechanism for the net inhibition of macro calcium currents in response to either μ- or 
κ-opioid inhibition is being currently proposed (See Chapter VI). 
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Figure 1.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.1  The hypothalamo-neurohypophysial system contains magnocellular 
neurosecretory cells which send projections down to the neurohypophysis. There 
terminals secrete arginine-vasopressin (AVP) and oxytocin (OT) into the capillary 
bed.  Figure from Lemos, 2002. 
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Figure 1.2 
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Figure 1.2 Burst Frequency is important in Neuropeptide Secretion. AVP 
and OT release are elicited through action potentials which travel down from the cell bodies 
(middle box). Both AVP and OT secretion is determined by the frequency of firing in bursts 
of action potentials. Bottom traces show OT secretion is optimized with firing frequencies 
between 65 and 100 Hz. Top traces show secretion of AVP from the neurohypophysis is 
optimized by short phasic bursts of action potentials with a mean intraburst frequency around 
10 -20 Hz. Figure adapted from Dr. Govindan Dayanithi (U. Montpellier II, France). 
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Figure 1.3   Potential intracellular calcium stores.  An EM of individual terminals in 
the neurohypophysis shows organelles such as the mitochondria as well as secretory 
granules containing AVP or OT. Outlined are potential intracellular calcium stores, and 
calcium extrusion mechanisms known to be present in the HNS terminals, as well as 
pharmacological agents that block each of these.  Figure from Sasaki et al., 2005. 
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Figure 1.4 
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Figure 1.4 Depolarizing Pre-Pulse Protocol. A. Voltage protocols designed for the 
application of a depolarizing Pre-Pulse (DPP). B. The DPP was designed to knock-off 
the Gβγ subunit from direct inhibitory association to the cytoplasmic link I-II region of 
the VGCC. C. Dissociation o the Gβγ subunits relieves VGCC inhibition allowing 
increased calcium influx through the channel. Figure inspired by C.F. Barrett, Ph.D 
thesis (2001). 
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Figure 1.5 
Ryanodine- 
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Figure 1.5. Membrane diffusible second-messenger signaling. Classic Gα coupling with different 
diffusible second-messenger systems. Gs and Gi/o are typically associated with the activation or inhibition, 
respectively, of adenylyl cyclase leading to changes in cAMP intracellular concentrations. Gq activation is 
characterized by activation of the phospholipase C pathway which activates IP3 receptors liberating internal 
calcium from IP3 calcium stores, diacylglicerol and protein kinase C. Gq/11 has been shown to activate the 
phospholipase A2 πατηωαψ. Α ψετ υνκνοων Γα protein mediates activation of the ADP ribose cyclase 
initiating production of cADPr and release of intracellular calcium from ryanodine-sensitive stores. Figure 
modified from Sigma Signal Transduction Catalogue (2004). 
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Figure 1.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6  The hypothalamo-neurohypophysial system contains magnocellular neurosecretory cells 
which send projections down to the neurohypophysis. Endogenous opioid inputs to the magnocellular 
neurosecretory system which potentially target VCGG include enkephalins form the pars intermedia 
(Rossier et al., 1980), endomorphin from the arcuate nucleus (Chen et al., 2004; Hui et al., 2006), met-
enkephalin (Leng et al., 1994) and dyanorphin A co-released with OT and AVP respectively (Bondy, 
1988) (A). Diagram of individual terminals in the neurohypophysis shows the presence of both κ- and µ-
opioid receptors and the respective voltage-gated calcium channels (VGCC) present in each terminal 
subtype. Also shown are organelles such as the mitochondria as well as secretory granules containing 
AVP or OT. Arrows indicate the release of AVP (co-released with Dyanorphin A) and OT (co-released 
with MetEnkephalin) along with endogenous opioid input from other systems and following κ-receptor 
activation, intraterminal arrows indicate VGCC targets (B). Modified and/or adapted from Lemos et al., 
2002, and Ortiz-Miranda, unpublished. 
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Extracellular calcium is not necessary for all depolarization-
induced neuropeptide secretion from CNS terminals 
 
Extracellular calcium is not necessary for all depolarization-induced 
neuropeptide secretion from CNS terminals 
Cristina Velázquez-Marrero, Edward E. Custer, Valérie De Crescenzo, Kevin E. Fogarty,  
John V.Walsh, Jr., and José R. Lemos 
 
 Depolarization-secretion (DSC) coupling is thought to be exclusively dependent on 
extracellular calcium (Douglas and Poisner, 1964; Katz, 1969).  Competing theories (Parnas 
and Parnas, 1986; Zhang and Zhou, 2002; Khanin et al., 2006), however, hypothesize that 
voltage may be a key factor in initiating fast release. Recently, voltage-activated ryanodine-
sensitive Ca2+ release events (“syntillas”) have been described in neurohypophysial terminals 
(De Crescenzo et al., 2004a; De Crescenzo et al., 2006). Could mobilization of Ca2+ from 
intracellular stores by depolarization trigger neuropeptide release? We now demonstrate that 
depolarization in the absence of extracellular calcium induced by either High K+ or electrical 
stimulation can give rise to neuropeptide release from Hypothalamic Neurohypophysial 
System (HNS) terminals. Agents that block voltage-gated calcium channels (VGCCs) did not 
block this depolarization-induced release. To help determine whether intraterminal calcium 
was involved in neuropeptide release in response to High K+ in 0 mM = [Ca2+]o, increases in 
intracellular calcium were buffered by pre-incubating with Bapta-AM. This resulted in over 
50% inhibition of release by both High K+ stimulation in 0 mM [Ca2+]o, as well as in normal 
extracellular Ca2+. The remaining intraterminal calcium-independent neuropeptide release 
may be due to calcium-independent voltage-dependent (CIVD) release (Zhang and Zhou, 
2002; Zhang et al., 2004; Yang et al., 2005). Given the existence of ryanodine-and voltage-
sensitive Ca2+ stores in HSN terminals (De Crescenzo et al., 2004b; De Crescenzo et al., 
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2006) we tested whether these stores could elicit neuropeptide release. Interestingly, caffeine 
(3-20 mM) and other RyR agonists, such as ryanodine (10 μM), and imperatoxin A (10 and 
100 nM), elicited peptide release from populations of isolated HNS terminals in the absence 
of extracellular calcium. These agonists also elicited increases in intraterminal calcium as did 
High K+ in 0 mM [Ca2+]o. However, in the absence of [Ca2+]o caffeine- but not High K+-
evoked release of neuropeptide was partially inhibited by 100 μM ryanodine.  This strongly 
suggested that ryanodine-sensitive voltage-activated Ca2+ stores are not involved in High K+-
evoked (in 0 mM [Ca2+]o) release. Nevertheless, our results clearly show that extracellular 
calcium is not necessary for all depolarization-induced neuropeptide secretion from these 
CNS terminals. 
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 INTRODUCTION 
 
 Calcium influx through voltage-gated calcium channels (VGCC) has had a central 
role in neurotransmitter release since studies first identified its importance in presynaptic 
function and exocytosis (Douglas and Poisner, 1964; Katz, 1969; Llinas, 1977; Silinsky, 
1985; Wojtowicz and Atwood, 1986; Augustine et al., 1987; Zucker, 1993; Berridge, 1998; 
Branchaw et al., 1998; Kasai et al., 1999; Atwood, 2006). In contrast, Ca2+ release from 
internal stores in nerve terminals is poorly understood and somewhat controversial. 
Nevertheless, mounting evidence suggests that internal Ca2+ stores contribute to presynaptic 
function. Ca2+ influx during action potentials triggers Ca2+-induced calcium release (CICR) 
from ryanodine-sensitive stores (Narita et al., 2000) and caffeine suppression of glutamate 
release can regulate synaptic transmission from retinal rod photoreceptors (Krizaj et al., 
1999). Furthermore, Ryanodine-sensitive calcium release and Ca2+/calmodulin-dependent 
kinase II (CaMKII) have been shown to be essential for post-tetanic potentiation of 
neuropeptide secretion (Shakiryanova et al., 2007). 
 The Hypothalamic-Neurohypophysial system (HNS) has proven to be a useful model 
system to study depolarization-secretion coupling (Wang et al., 1993a; Lemos, 2002). The 
peptide hormones arginine-vasopressin (AVP) and oxytocin (OT) are released from nerve 
terminals of the magnocellular neurons (MCN) of the neurohypophysis. Although it had been 
previously reported that there were no caffeine-sensitive stores in the neurohypophysis 
(Stuenkel, 1994), recent work (De Crescenzo et al., 2004a) has identified voltage-sensitive 
Ca-sparks (“syntillas”) which emanate from ryanodine-sensitive stores. In the HNS, High K+ 
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and electrical-stimulation induces peptide release from the HNS, which is not completely 
inhibited by VGCC blockers, such as toxins (Wang et al., 1999a; Wang et al., 2002a) or 
Ni2+/Cd2+ (Cazalis et al., 1987b; Stuenkel and Nordmann, 1993b; Turner and Stuenkel, 
1998). However, there has been no demonstration of a mechanism whereby depolarization, in 
the absence of Ca2+ influx, causes neuropeptide release from terminals through release of 
calcium from internal stores. Here we demonstrate that release of both AVP and OT is 
increased by depolarization in the absence of calcium influx through VGCCs. However, 
unexpectedly, this release is due, in part, to intraterminal calcium increases from ryanodine-
insensitive stores. To the best of our knowledge, this is the first direct demonstration of 
voltage-dependent yet extracellular calcium-independent neuropeptide release elicited in part 
by calcium stores within nerve terminals. 
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 METHODS 
Assay for peptide release 
 The experiments were conducted on freshly dissociated Neurohypophysial NH nerve 
terminals of male Swiss Webster adult (6-8 weeks) mice (Taconic Farms, USA) unless 
otherwise stated. The mice were cervically dislocated and decapitated (as approved by the 
University of Massachusetts Medical School protocol A-1135), the brain was removed and 
the pituitary then excised. The isolated neurohypophysis was homogenized in a solution 
containing (mM); sucrose, 270; Tris-Hepes, 10 (pH 7.25); EGTA 0.2. The homogenate was 
centrifuged at 100xg for 2 min. and the resulting pellet was centrifuged at 2400 x g for 6 min. 
The final pellet contains highly purified nerve terminals. The isolated nerve terminals were 
loaded onto filters (0.45 mm Acrodisc, Gelman Scientific, Ann Arbor, MI, USA) and 
perfused at 37oC with Locke’s solution (Cazalis et al., 1987c). The modified Locke’s solution 
contains (mM): NaCl, 100; CaCl2, 0.0022; KCl, 5; N-methyl-D-glucamine (NMG)-Cl2, 45; 
MgCl2, 1; glucose, 10; HEPES, 10 (pH 7.4). Ca
2+ free solution contained (mM): NaCl, 100; 
EGTA, 0.002; KCl, 5; N-methyl-D-glucamine (NMG)-Cl2, 45; MgCl2, 1; glucose, 10; 
HEPES, 10 (pH 7.4), and gave a calculated free [Ca2+] of zero. The Ca2+ free solution was 
further tested using a Ca2+ probe which determined the Ca2+ concentration in the solution to 
be below 10 nM, its lowest sensitivity reading. Fractions of perfusate were collected at 4 min. 
intervals and release was evoked by a 30-45 min. exposure to Locke’s with High K+ (45 mM 
NMG-Cl exchanged for 45 mM KCl) or ryanodine agonists, e.g. 20 mM caffeine (Sigma). A 
specific and sensitive enzyme-linked immunoassay (ELISA: Assay Designs, Inc.; Ann 
Arbor, MI) was used to determine the content of AVP and/or OT for individual terminals 
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isolated and collected as described above. The results are given as AVP or OT release per 
fraction measured. In all cases, data are reported as mean ± SEM; n being the number of 
terminals or loaded filters. Statistical analysis of differences were made with paired t-tests, 
with p≤ 0.05 considered significant. 
 
Calcium imaging 
 Freshly dissociated nerve terminals (Nordmann et al., 1987) prepared from adult 
Swiss Webster mice (De Crescenzo et al., 2004a) were incubated with 2.5 μM Fura-2 AM 
for 45 min. at 37oC and thoroughly washed with Normal Locke’s solution.  Normal Locke’s 
contained (mM): 145 NaCl, 5 KCl, 10 Hepes, 10 Glucose, 1 MgCl2 and 2.2 CaCl2, pH 7.4.  
Ca2+ free bath solution contained (mM): 145 NaCl, 5 KCl, 10 Hepes, 10 Glucose, 0.0002 
EGTA, 1 MgCl2, pH 7.4, and gave a calculated free [Ca
2+] of zero. The Ca2+ free bath 
solution was further tested using a Ca2+ probe which determined the Ca2+ concentration in the 
solution to be below 10 nM, its lowest sensitivity reading. Cytosolic [Ca2+] was determined 
with ratiometric indicator fura-2 AM loaded terminals and calibrated utilizing an in-vitro 
calibration kit (Invitrogen, Carlsbad CA).  This was performed according to the method of 
(Grynkiewicz et al., 1985) with an assumed Ca2+-fura 2 KD of 200 nM, as previously 
described (Becker et al., 1989). Resting values for global cytosolic [Ca2+] in the presence and 
absence of extracellular Ca2+ were 73.3 ± 6.9 nM (n = 12) and 46.2 ± 7.5 nM (n = 8), 
respectively, and these values demonstrated a statistically significant difference (p < 0.05).  
In all cases, data are reported as mean ± SEM; n being the number of terminals. Statistical 
analyses of differences were made with paired t-tests, with p < 0.05 considered significant. 
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 Fluorescence images using Fura-2 AM as a calcium indicator were viewed with a 
Nikon Diaphot TMD microscope, using a Zeiss Plan- NEOFLUAR 100X oil immersion lens, 
and fitted with a Photometrics SenSys CCD camera. The camera was interfaced to the 
inverted microscope adapted with a Chroma 71000A Fura2 filter cube. The terminals were 
excited using a Xenon arc lamp within a Lambda DG4 high-speed filter changer (Sutter 
Instruments Incorporated, Novato,CA) with the appropriate filters (340 and 380 nm 
wavelengths). Intraterminal emission of Fura-2 Ca2+ indicator was gathered at 510 nm 
wavelength. Fluorescent images were acquired and processed with Axon Imaging 
Workbench 2.1 software (Axon Instruments, Foster City, CA). 
 
Capacitance Measurements 
 Freshly dissociated terminals (Nordmann et al., 1987) from adult Swiss Webster mice 
were plated in Normal Locke’s solution with 1.2 mM CaCl2. Tight seal “whole terminal” 
recordings were obtained using the perforated-patch configuration described above. The 
pipettes resistance ranged from 5-8 MΩ. Perforation of the terminals’ membrane was 
obtained by adding 30 μM amphotericin B (SIGMA) to the pipette solution containing (mM): 
145 Cs-gluconate, 15 CsCl, 5 NaCl, 2 MgCl2, 7 Glucose, 10 HEPES pH 7.3. The bath 
solution contained (mM): 145 NaCl, 5 KCl, 1 MgCl2, 10 HEPES, 10 Glucose, 1.2 CaCl2 or 
0.2 EGTA, pH 7.5. Capacitance measurements were obtained using the piecewise-linear 
method (Knott et al., 2007). The changes in capacitance induced by a depolarizing pulse (750 
ms duration) were measured 1 second after cessation of stimulus, in order to avoid 
interference of stimulus “end-tail” effects. These stimulus-induced capacitance changes were 
measured for isolated terminals (perforated-patch) using the piece-wise method (Neher and 
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Marty, 1982; Lindau and Neher, 1988; Gillis, 1995). Briefly, the method consists in applying 
a sinusoidal voltage of low amplitude to the sample (in order to avoid voltage-elicited 
channel currents) and obtaining the phase shift of the resultant sinusoidal current. Changes in 
this phase shift (“locked-in”) are used in a formula (computer software that emulates a lock-
in amplifier) for the determination of the capacitance changes (i.e., the capacitance that 
would cause such change of phase shift). The method is sensitive to very small changes in 
capacitance and, in practice, large baseline capacitance and resistance (series) transients must 
be compensated (i.e., null) before measuring any small capacitance change. In this particular 
case the parameters used were a sine wave of 1000 Hz at ± 25 mV (about holding potential), 
with the program reporting a capacitance averaged for every 30 points (24 µs sampling rate). 
The current was filtered at a bandwidth of 5000 Hz.   
 
 
 
 
RESULTS 
 
Depolarization- induced release of both neuropeptide and [Ca2+]i : 
To investigate whether depolarization-induced release occurs in the absence of 
extracellular calcium we first monitored hormone release in response to 50 mM KCl (High 
K+) challenges in both normal calcium (2.2 mM) Lockes (NL) and calcium-free Lockes 
buffered with 2 mM EGTA. In NL, AVP hormone release increases to 576 ± 140% above 
baseline upon High K+ challenge. In 0 mM [Ca2+]o, High K+ is still able to increase AVP 
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release 223 ± 31% above baseline (Fig. 2.1A). High K+-induced neuropeptide release in the 
absence of extracellular calcium represents 39% of the release observed in 2.2 mM [Ca2+]o. 
Previous experiments had shown that High K+ induced release occurred with 2.2 mM [Ca2+]o 
even in the presence of all known voltage-gated Ca-channel (VGCC) blockers (Wang et al., 
1997b; Wang et al., 2002a). This suggested that a fraction of the High K+-induced release 
was VGCC-independent. Furthermore, we now demonstrate that High K+-induced [Ca2+]i 
rise is only partially blocked by 100 μM Ni2+/Cd2+ (Fig.2.2), well characterized non-specific 
VGCC blockers (Salzberg et al., 1983; Cazalis et al., 1987b; Keja et al., 1991; Stuenkel and 
Nordmann, 1993b; Fisher and Bourque, 1995; Wang et al., 1999b; Luther and Tasker, 2000; 
Wang et al., 2002b; Marrero and Lemos, 2003). To test whether the release observed with 
High K+ in 0 mM [Ca2+]o was  also VGCC-independent we applied these VGCC blockers, 
Ni2+/Cd2+ at 100 μM (Fig. 2.3A&B). Changes in AVP release were quantified as percent 
release above baseline (Fig. 2.3B). Results show High K
+
 in 0 mM [Ca
2+
]o = 112.9 ± 15.2%, 
similar to High K
+
 in 0 mM [Ca
2+
]o with 100 μM Ni2+/Cd2+ = 120.9 ± 26.8%. Furthermore, 
High K
+
 in 2.2 mM [Ca
2+
]o was 249.7 ± 58%, but High K
+
 in 2.2 mM [Ca
2+
]o with 100 μM 
Ni
2+
/Cd
2+
 was only 85 ± 19.1%.  No statistical significant difference was observed between 
High K+-induced release of AVP with and without these calcium channel blockers in the 
absence of extracellular calcium. There was a statistically significant difference (p<0.03), 
however, between High K
+
 in 2.2 mM [Ca
2+
]o with and without 100 μM Ni2+/Cd2+. 
Furthermore, all treatments with 100 μM Ni2+/Cd2+ (with or without [Ca2+]o) and High K+ in 
the absence of [Ca2+]o, were not statistically different (p>0.05). This suggests a common 
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VGCC-independent component to depolarization-induced release in the presence and 
absence of [Ca2+]o. 
Importantly, capacitance measurements on individual HNS terminals in 0 mM [Ca2+]o 
show an  increase in capacitance of 24.2 ± 4 fF following a 750 ms square pulse stimulus 
from -80 mV to 0 mV (Fig. 2.1B). This represents a 22.3 ± 3.6% rise in capacitance in 
comparison to the same electrical stimulation under normal calcium conditions. The 
electrical stimulation was chosen for its ability to elicit maximum calcium currents (see inset 
in Fig. 2.1B) and substantial capacitance increase of 106.6 ± 8.8 fF in 1.2 mM [Ca2+]o 
conditions (Fig. 2.1B). Calcium currents under the same 0 mM [Ca2+]o conditions were 
completely blocked (Fig. 2.1B inset). Peak capacitance measurements in the absence of 
extracellular calcium were statistically significantly different from controls (p<0.002; n=4). 
Therefore, our results demonstrate there is release of neuropeptide from both a population 
and from individual terminals in response to depolarizing stimuli in the absence of [Ca2+]o. 
 
Changes in [Ca2+]i during depolarization in the absence of [Ca2+]o : 
 To investigate whether High K+ depolarization-induced release in the absence of 
extracellular calcium is associated with intraterminal calcium changes, we monitored 
intracellular calcium concentrations in response to a High K+ challenge. Calcium imaging 
using fura-2 AM confirmed a cytosolic rise in [Ca2+]i in response to the High K+ challenge in 
0 mM [Ca2+]o  equivalent to a 150 ± 50%  rise above baseline (Fig. 2.4A) equivalent to 84.2 ± 
17.0 nM; (n=4) change in baseline [Ca2+]i.  In the presence of 100 μM ryanodine the change 
in baseline [Ca2+]i = 22.8 ± 7.2 nM; (n=4) in response to High K+ challenge in 0 mM [Ca2+]o  
which represents a 73% inhibition by the ryanodine antagonist (Fig.2.4B). This correlates 
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well with previously reported measurements of 100 μM ryanodine inhibition of global [Ca2+]i 
rise in response to 400 ms duration depolarizing pulses of 20-40 mV (De Crescenzo et al., 
2004a). Therefore, depolarization initiates a rise in intracellular calcium in the absence of 
extracellular calcium, presumably via release of Ca2+ from an intracellular store, possibly 
ryanodine-sensitive. This leads to an important question. Is the rise in [Ca2+]i necessary for  
depolarization-induced release in the absence of extracellular calcium? 
 
Buffering of [Ca2+]i during depolarization- induced release of both neuropeptide and 
[Ca2+]i in the absence of [Ca2+]o : 
 To determine if the rise in [Ca2+]i in response to High K+ is necessary for High K+ -
induced release of neuropeptide in 0 mM [Ca2+]o we buffered changes in [Ca2+]i using Bapta-
AM. High K+ -induced release of neuropeptide in 0 mM [Ca2+]o is partially inhibited by 
preincubation with the calcium chelator, Bapta-AM at 26 μM (Fig. 2.5). High K+ in 2.2 mM 
[Ca2+]o was inhibited to 47 ± 5% of control (without Bapta-AM preincubation) and High K+ 
in 0 mM [Ca2+]o was reduced to 59 ± 5% of control (without Bapta-AM preincubation) (Fig. 
2.5C). Therefore, approx. half of High K+ in 0 [Ca2+]o induced neuropeptide release is due 
directly to intraterminal calcium. Furthermore, rises in intraterminal calcium were blocked by 
98 ± 4% in High K+ in 0 mM [Ca2+]o and inhibited by 79 ± 8 % when challenged with High 
K+ in 2.2 mM [Ca2+]o (Fig. 2.6). HNS terminals pre-incubated with 26 μM Bapta-AM 
demonstrated no statistically significant (p>0.05) rise of [Ca2+]i in response to High K+ in 0 
mM [Ca2+]o with respect to baseline [Ca2+]i. There was, however, a statistically significant 
difference between the 26 μM Bapta-AM pre-incubated terminals in NL in response to High 
K+ (p<0.05). Presumably influx of Ca2+ through VGCC when in NL may saturate Bapta’s 
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ability to buffer [Ca2+]i. This however, is clearly not the case when in 0 mM [Ca2+]o. 
Therefore, persistent release of neuropeptide in response to High K+ after pre-incubation with 
Bapta-AM in 0 mM [Ca2+]o, strongly suggests there is a calcium-independent yet voltage-
dependent component to depolarization-induced extracellular Ca2+-independent release 
(ECIR). Furthermore, 41% of the depolarization-induced ECIR is intraterminal Ca2+-
dependent. The question becomes whether the intraterminal Ca2+-dependent portion of 
neuropeptide release is due to Ca2+ released from ryanodine- and voltage-sensitive stores. 
 
Effects of ryanodine agonists on neuropeptide release: 
 Since release of [Ca2+]i from intraterminal stores is partially responsible for 
depolarization-induced ECIR, we tested whether release from ryanodine-sensitive stores 
could elicit neuropeptide release in the absence of [Ca2+]o. Caffeine is a xanthine that releases 
[Ca2+]i from intracellular stores by increasing the affinity of the ryanodine receptor for 
cytoplasmic Ca2+ (Pozzan et al., 1994; Hernandez-Cruz et al., 1995). In isolated 
neurohypophysial terminals, application of caffeine evokes the release of calcium from 
intracellular stores (De Crescenzo et al., 2004b). This release is typically observed as a 
transient global increase in [Ca2+]i reminiscent of that observed with High K+ in 0 mM 
[Ca2+]o (Fig. 2.5A). Figure 2.7B quantifies the average change in [Ca2+]i in response to 20 
mM caffeine = 20.2 ± 3.1 nM; (n=7), representing a 33% rise from baseline. The High K+ in 
0 mM [Ca2+]o challenge elicited a 24.2 ± 1.9 nM; (n=7), change in [Ca2+]i which represents a 
40% rise from baseline (Fig. 2.7B). The average changes in  [Ca2+]i for the 20 mM caffeine 
as compared to the High K+ in 0 mM [Ca2+]o challenge were not statistically different (p > 
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0.05). However, both challenges were statistically different from baseline [Ca2+]i values with 
p < 3.43e-5.  
 Application of 20 mM caffeine evokes concentration-dependent hormone release 
from a population of HNS terminals (Fig.2.8). Furthermore, at the single terminal level, a 20 
mM caffeine in 0 mM [Ca2+]o challenge results in a rise in membrane capacitance of 103.0 ± 
45.6 fF, indicative of exocytotic release. This response is not dependent on VGCCs since 100 
μM Ni2+/Cd2+ had no effect on caffeine-evoked hormone release (Fig. 2.3B).  
 Repetitive challenges with 20 mM Caffeine in calcium free Normal Locke’s did not 
diminish the [Ca2+]i rises nor the hormone release response (Fig. 2.9) in 0 mM [Ca2+]o. This 
allowed for cross-comparisons between experimental approaches regardless of technical 
differences. Four 30 second applications of 20 mM caffeine, 1 min. apart increased 
neuropeptide release: 98%, 78%, 86%, and 97 % above baseline, respectively. No differences 
were observed between the release evoked by the first and last application of 20 mM 
caffeine. Prolonged application (7 min.) of 20 mM caffeine also elicited a sustained response. 
This further confirmed that the internal calcium stores in the isolated terminals are very 
difficult to deplete.  
 Caffeine is by no means the only RyR agonist capable of eliciting hormone release 
from neurohypophysial terminals. The concentration-dependent response described above 
extends to Imperatoxin A (Table 2.1), a highly specific RyR agonist (Valdivia et al., 1992).  
In our hands, Imperatoxin A is capable of inducing both a rise in intracellular calcium and an 
increase in AVP release at concentrations as low as 0.1 nM.  The activation properties of 
Imperatoxin A during its association to the RyR are known to be concentration-dependent 
(EC50=10 nM), with a fast onset and fully reversible (el-Hayek et al., 1995).  Imperatoxin A 
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showed a similar concentration-dependent response in its ability to evoke both a rise in 
intraterminal calcium and release of neuropeptide (Table 2.1). Furthermore, application of 
ryanodine at a 10 μM concentration, also elicited increases in both [Ca2+]i and basal hormone 
release (Table 2.1).  Therefore, release of [Ca2+]i from ryanodine-sensitive stores is capable 
of triggering neuropeptide release from HNS terminals. 
 
Ryanodine-sensitive Ca2+ stores do not make a significant contribution to voltage-
dependent release in the absence of [Ca2+]o 
 In some types of cells, ryanodine at higher concentrations (100 μM) can block 
caffeine-induced release of Ca2+ from ryanodine-sensitive intracellular stores (McPherson et 
al., 1991). Furthermore, caffeine has been shown to cause release of calcium from ryanodine-
insensitive stores (Schmid et al., 1990; McNulty and Taylor, 1993; Orkand and Thomas, 
1995). Therefore, to determine if the calcium released from ryanodine-sensitive stores is 
responsible for the intraterminal Ca2+-dependent potion of depolarization-induced ECIR, we 
tested the effects of an antagonist concentration of ryanodine on the caffeine- and High K+- 
induced neuropeptide release seen in the absence of extracellular calcium. Caffeine- but not 
High K+-evoked (in 0 mM [Ca2+]o) release of neuropeptide was partially inhibited, by 40 ± 
14%, in the presence of 100 μM ryanodine (Fig. 2.10B).  Previous reports (De Crescenzo et 
al., 2004a) have shown that 100 μM ryanodine inhibited the caffeine-induced rise in syntilla 
frequencies to a similar extent. However, High K+-evoked (in 0 mM [Ca2+]o) neuropeptide 
release was not statistically different (p>0.05) from High K+-evoked (in 0 mM [Ca2+]o) 
neuropeptide release in the presence of 100 μM ryanodine (Fig. 2.10B). Interestingly, we 
have shown that application of 100 μM ryanodine was able to inhibit approximately 75% of 
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the elevation of [Ca2+]i due to a High K+ challenge in 0 mM  [Ca2+]o (Fig. 2.4B). However, 
we must conclude that release of [Ca2+]i from voltage- and ryanodine-sensitive stores does 
not significantly contribute to neuropeptide release in response to High K+ in 0 mM [Ca2+]o.  
  
 
 
DISCUSSION 
 
 Our studies show that depolarization, in the absence of external calcium, elicits 
release of neuropeptide from both individual and populations of HNS terminals. This release 
of peptide hormone was triggered, at least partially, by release of calcium from intraterminal 
stores. These findings broaden our view of potential sources of presynaptic calcium and 
subsequent dependence on extracellular calcium for depolarization-secretion coupling 
(DSC). The classical precept of DSC states that depolarization of the membrane due to an 
action potential opens voltage-gated calcium channels, allowing Ca2+ ions to flow in. The 
basis of the Calcium Hypothesis (CH) is that the post-stimulation rise in intracellular 
calcium, in the vicinity of sites of exocytosis, is the sole trigger for neurotransmitter release 
(Katz, 1969; Zucker, 1993). The subsequent removal of calcium from these sites terminates 
the process. Recently work has suggested that Ca2+ is required, yet insufficient for fast 
release to occur.  This has led to an alternate Ca2+-voltage hypothesis (CVH) (Parnas et al., 
2002; Khanin et al., 2006) which proposes that membrane potential (i.e., depolarization) is 
the key step in initiating depolarization-induced exocytosis, while repolarization controls its 
termination. We, and others, have observed that High K+ and electrical stimuli induce an 
“extracellular calcium-independent” form of peptide release from the HNS, which is not 
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completely blocked by VGCC blockers, such as toxins (Wang et al., 1999a; Wang et al., 
2002a) or Ni2+/Cd2+ (Stuenkel and Nordmann, 1993b; Turner and Stuenkel, 1998). This 
coupled with the recent characterization of voltage-dependent Ca2+ syntillas (De Crescenzo et 
al., 2004a; De Crescenzo et al., 2006) led to the question: could mobilization of intracellular 
calcium stores lead to the “extracellular calcium-independent” hormone release?  
Depolarization-induced ECIR is not due to Ca2+ released from ryanodine-sensitive 
stores  
 Here we have demonstrated that in isolated HNS terminals depolarization-dependent 
release observed in 0 mM [Ca2+]o is, at least partially, due to release of intracellular Ca2+ 
from calcium stores.  To our surprise, part of this intracellular calcium-dependent release was 
shown to be ryanodine-insensitive. The remaining non-calcium yet voltage-dependent release 
could be due to changes in intracellular sodium, which has been shown to affect hormone 
release in this system (Stuenkel and Nordmann, 1993b).  Alternatively a yet unknown, 
presynaptic inhibitory autoreceptor, as proposed by (Parnas and Parnas, 1994), could be 
responsible for exclusively voltage-dependent release. However, having shown that DSC 
occurs in the absence of extracellular calcium and independent of VGCCs supports the 
general premise of the Ca2+-voltage hypothesis. Whether this process modulates or plays a 
key role in the initiation and/or the termination of physiological release during a burst of 
action potentials in the HNS remains to be proven. 
Possible physiological role of ryanodine-sensitive stores during DSC 
 Large dense-core vesicle (LDCV) release is characterized by multiple steps involving 
populations of LDCVs in differing stages of exocytotic readiness (Horrigan and Bookman, 
1994; Seward et al., 1995; Giovannucci and Stuenkel, 1997). Early experiments describe a 
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triphasic capacitance response to depolarizing stimuli of peptidergic nerve terminals 
characterized by a critical initial “threshold phase” which does not trigger hormone release 
(Seward et al., 1995).  Giovannucci and Stuenkel (1997), suggested that the activation of 
unknown Ca2+-dependent steps prepare the granules of the readily-releasable pool for 
secretion. Intraterminal calcium stores may act as pivotal modulators of the state of 
exocytotic readiness of any given terminal prior to and/or during electrical stimulation. 
Therefore, one prediction would be that experimentally elevating [Ca2+]i via release of 
intraterminal calcium would meet the threshold calcium level requirement prior to DSC. This 
could effectively amplify the subsequent depolarization-secretion response by transiently 
maximizing the number of LDCV in a primed state for release. Such receptor-independent 
potentiation due to ryanodine-sensitive calcium stores has been recently reported in rat 
hippocampal area CA1 (Li et al., 2006). These studies showed that caffeine enhances this 
form of LTP. More recently, RyR and CaMKII have been shown to be essential for post-
tetanic potentiation of neuropeptide secretion in Drosophila motor neuron terminals 
(Shakiryanova et al., 2007). In isolated HNS terminals, blocking ryanodine receptors using 
either 100 μM ryanodine or 8-Br cADPr, attenuated both the depolarization-induced release 
of OT and the rise in [Ca2+]i due to High K+, with extraterminal calcium present (Jin et al., 
2007). Although our current study shows that ryanodine receptor agonists stimulate basal 
release of neuropeptide, ryanodine-sensitive stores do not seem to play a significant role in 
depolarization-induced ECIR.  Their contribution may be limited by how much intraterminal 
calcium is present in an extraterminal calcium free environment. Under physiological 
conditions amplification of a depolarization-induced release may require calcium influx from 
VGCC to trigger CICR, thus potentiating the neuropeptide release response.  
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Other possible stores of intraterminal Ca2+ in HNS terminals 
 Release from intracellular stores in response to High K+ in calcium free medium may 
be triggered by release of calcium from inositol- 1.4,5-trisphosphate (IP3) intracellular stores 
in the HNS (Sabatier et al., 2004; Ludwig and Leng, 2006). Our results support this 
possibility given there is a portion of the [Ca2+]i rise due to High K+ stimulation in 0 mM = 
[Ca2+]o which is not blocked by antagonist concentrations of ryanodine. Furthermore, in 
permeabilized terminals, treatment with IP3 induced a 242% rise above baseline of AVP 
release (Cazalis et al., 1987a) indicating IP3 stores not only exist in terminals but are capable 
of participating in release. In magnocellular oxytocin neurons, IP3 stores have also been 
shown to contribute to OT release in the absence of extracellular calcium (Richard et al., 
1997). Other systems, such as Torpedo cholinergic synaptosomes, show increases in IP3 
production in response to a depolarizing stimulus (Carrasco et al., 1996). However, the exact 
mechanism involved in IP3 production during DSC in cholinergic synaptosomes, is still 
unknown and seems to require the presence of extracellular calcium. 
Physiological significance of depolarization-induced ECIR 
 Concurrently, voltage-dependent calcium-independent release could maintain the 
efficacy of neuropeptide release at the HNS terminals during high-frequency burst 
stimulation originating from the MNC neurons in the supraoptic and paraventricular nuclei. 
During high frequency bursts the interstitial space surrounding the HNS terminals in situ 
would be depleted of Ca2+ towards the latter part of the burst, conditions which do not favor 
calcium influx through VGCC.  Zhang and Zhou (2002) have shown in DRG somata, that 
High K+-induced exocytosis occurred in the absence of a detectable [Ca2+]i change.  They 
ascribed this as direct evidence of the existence of calcium-independent but voltage-
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dependent secretion (CIVDS). Our results demonstrate that both CIVDS and intraterminal 
calcium release can contribute to the release of neuropeptides from HNS terminals. This is 
the first time, to the best of our knowledge, that a CIVDS has been found at a peptidergic 
terminal (Zhang and Zhou, 2002; Zhang et al., 2004; Yang et al., 2005). An extracellular 
calcium-independent but voltage-dependent mechanism for release could explain the efficacy 
of release at the end of an HNS burst in situ when [K+]o would depolarize the NH terminals, 
but [Ca2+]o would normally be depleted within the NH  interstitial space (Leng and Shibuki, 
1987; Leng et al., 1988a; Marrero and Lemos, 2005). 
Conclusion 
In conclusion, our results indicate that depolarization-induced neuropeptide release is 
present in the absence of external calcium, and calcium release from ryanodine-insensitive 
internal stores is an important contributor to this release from NH terminals. We have further 
shown that in isolated HNS terminals, there is a component of depolarization-induced ECIR 
that is also independent of intraterminal Ca2+. This strongly suggests that there is a CIVD 
mechanism in HNS presynaptic structures involved in DSC. Given the in situ physiological 
conditions of most presynaptic structures in the CNS, voltage-dependent and extraterminal 
calcium-independent neuropeptide release may be an important mechanism involved in DSC 
during high frequency stimulation at many CNS terminals. 
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Figure 2.1 
A. B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.1 Effect of calcium on depolarization-induced exocytosis. A. High K+-
induced AVP neuropeptide release with and without [Ca2+]o. Fractions collected 
every 4 min. B. Capacitance measurements of single terminal in the presence 
(red) and absence (blue) of extracellular calcium stimulated with a square pulse 
of 80 mV for a duration of 750 ms. Inset shows the currents obtained from the 
actual stimulus (same color indicators). The generalized conductance changes 
(“G”) are shown for reference. Dashed gray lines represent the zero-change 
baselines. Peak capacitance measurements in the absence of extracellular 
calcium were statistically significantly different from controls (p<0.002; n=4). 
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 Figure 2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Intraterminal calcium rise in response to depolarization in the absence of 
calcium influx through VGCC. A. Images of Fura-2 AM loaded single terminal 4 
seconds apart challenged with High K+ in 2.2 mM [Ca2+]o for 10 sec. with and without 
toxins specifically blocking VGCC: Nicardipine (1-2 mM), SNX 482 (20-30 nM), 
SNX 230 (100-200 nM) , ω-conotoxin MVIIC (100 nM) to block L-, R-, N-, and Q-
type calcium channels, respectively. Diameter of the terminal is approx. 4 μm. Control 
baseline [Ca2+]i = 96.8 ± 2.8 nM and baseline [Ca2+]i after incubation with toxins 99.4 
± 7.2 nM. B. Bar graph of change in [Ca2+]i in response to High K+ challenge in 2.2 
mM [Ca2+]o with and without incubation with VGCC blocker toxins (n=8 each). 
Asterisk (*) represents statistically significant difference (p<0.001).  
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 Figure 2.3 
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Figure 2.3 AVP release in response to High K+ in [Ca2+]o=2.2 mM, High K+ in 
[Ca2+]o=0 mM, and 20 mM caffeine with and without 100 μM Ni2+/Cd2+. A. 
Release of AVP from rats in response to High K+ in 0 mM [Ca2+]o control 
(black: n=3) and in the presence of 100 μM Ni2+/Cd2+ (red: n=3). Fractions 
collected every 4 min. B. Bar Graph quantifying the effects of 100 μM Ni2+/Cd2+ 
on High K+ in 2.2 mM [Ca2+]o, High K+ in [Ca2+]o= 0 mM and 20 mM Caffeine 
in 0 mM=[Ca2+]o. Asterisk (*) represents statistically significant difference 
(p<0.02).  
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 Figure 2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Calcium imaging in 0 mM [Ca2+]o of High K+ with and without 100 μM 
ryanodine. A. Calcium Imaging using Fura-2 AM showing intracellular calcium rise in 
response to 50 mM High K+ in the absence of extracellular calcium. Line trace points 
represent an average of intraterminal calcium concentration. Numbers correspond to 
designated time points. B. Bar graph of calcium rise as change in intraterminal calcium 
concentration (nM) of isolated terminals in 0 mM [Ca2+]o challenged with 50 mM KCl:  
Control and with 100 μM ryanodine. There was a statistically significant difference between 
Control High K+ in 0 mM [Ca2+]o and High K+ in 0 mM [Ca2+]o with 100 μM ryanodine 
(p=0.03). There is a statistical difference from baseline (p=0.02) for both treatments. Average 
baseline [Ca2+]i for all terminals = 74.9 ± 6.9 nM. Averages were calculated using the total 
number of points during the treatment and equal number of points for the baseline. Asterisk 
(*) represents statistically significant difference (p<0.05).  
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Figure 2.5 
Figure 2.5 Inhibition of AVP release with Bapta-AM pre-incubation. A. AVP release 
induced by High K+ in 2.2 mM [Ca2+]o  pre-incubated with 26 μM Bapta-AM (red line) and 
pre-incubated in carrier alone as control.  B. AVP release in High K+ in 0 mM [Ca2+]o pre-
incubated with 26 μM Bapta-AM (red line) and pre-incubated in carrier alone as control. C. 
Bar graph of Bapta-AM inhibition of High K+ with and without extraterminal calcium (n=3 
each). Averages were calculated using the total number of points during the treatment and 
equal number of points for the baseline. Asterisks (*) represent statistically significant 
differences (p<0.05).  
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Figure 2.6 
Figure 2.5   Intra-terminal Calcium rise in response to High K+ with and without pre-
incubation with Bapta-AM. A. Bar graph of change in [Ca2+]i in response to High K+ challenge 
in 0 mM [Ca2+]o with and without pre-incubation with 26 μM Bapta-AM (n=6) and with High 
K+ challenge in 2.2 mM [Ca2+]o with and without pre-incubation with 26 μM Bapta-AM (n=6). 
High K+ challenge in 0 mM [Ca2+]o with pre-incubation with 26 μM Bapta-AM is not 
statistically different from baseline. All other treatments are statistically different p<0.01 from 
baseline. B. Images of Fura-2 AM loaded single terminal 4 seconds apart challenged with High 
K+ in 0 mM [Ca2+]o for 10 sec. with and without pre-incubation with 26 μM Bapta-AM. 
Diameter of the terminal is approximately 6 μm. Control baseline [Ca2+]i = 108.3 ± 12.6 nM 
and baseline [Ca2+]i after pre-incubation with 26 μM Bapta-AM = 98.6 ± 11.3 nM. Asterisks 
(*) represent statistically significant differences (p<0.05).  
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Figure 2.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 Calcium imaging in 0 mM [Ca2+]o in response to High K+ and 
Caffeine. A. Trace representing [Ca2+]i changes taken over time (1 image/ 2 sec.) 
from a single NH terminal. B. Bar graph of changes in intraterminal calcium in 0 
mM [Ca2+]o when microperfused with High K+ or 20 mM Caffeine (n=7 for 
each). All Averages are statistically significantly different (p<3.43e-5) as 
compared to baseline. Mean baseline [Ca2+]i for all terminals = 60.4 ± 9.2 nM. 
Averages were calculated using the total number of points during the treatment 
and equal number of points for the baseline. 
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 Figure 2.8 
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Figure 2.8 Caffeine-induced release of AVP. A. Release of arginine-vasopressin 
(AVP) is evoked in a dose-dependent manner by caffeine. All show similar kinetics 
of sustained release in the absence of extracellular calcium. Fractions collected 
every 4 min. B. Bar graph of Caffeine-evoked release of AVP at (mM): 3, and 12 
(n=3 each) in the absence of extracellular calcium. Averages were calculated using 
the first three points during the treatment and equal number of points for the 
baseline. Asterisk (*) represents statistically significant difference (p<0.01). 
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Figure 2.9 
 
 
 
Figure 2.9 Repetitive stimulation with 20 mM Caffeine in 0 mM [Ca2+]o  
evoked similar increases in AVP release. Fractions collected every 9 sec. 
Short blue bars represent 1 min duration, 20 mM Caffeine treatments. A 
more prolonged 7 min. application (long blue bar) evoked a sustained 
response throughout. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 74
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1: Ryanodine receptor agonists trigger release of  
                           Arginine Vasopressin and [Ca2+]i. 
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Figure 2.10 
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Figure 2.10 Ryanodine (100 μM) effects on High K+- and Caffeine-induced 
AVP release in 0 mM [Ca2+]o. A. Caffeine (20mM) induced AVP release in 
the presence (red line) and absence (blue line) of 100 μM Ryanodine. B. Bar 
graph of Caffeine (20mM) and High K+ in 0 mM [Ca2+]o induced AVP 
release in the absence and presence of 100 μM Ryanodine, (n=3) and (n=6), 
respectively. Averages were calculated using the same number of points 
during the treatment as for the baseline. Asterisk (*) represents statistically 
significant difference (p<0.02). 
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Abstract 
Release of neurotransmitter is activated by influx of calcium (Katz and Miledi, 
1968). Inhibition of Ca2+ channels results in less calcium current influx into the terminal 
and presumably a reduction in transmitter release. In the neurohypophysis, Ca2+ channel 
kinetics, and the associated Ca2+ influx, is primarily controlled by membrane voltage and 
can be modulated, in a voltage-dependent manner, by G-protein subunits interacting with 
voltage-gated calcium channels (VGCC). Voltage-dependent relief of G-protein 
inhibition of VGCC is achieved with either a depolarizing square pre-pulse or by action 
potential waveforms. Both protocols were tested in the presence and absence of opioid 
agonists targeting the µ- and κ-receptors. The κ-opioid VGCC inhibition is relieved by 
such pre-pulses, suggesting that this receptor is involved in a voltage-dependent 
membrane delimited pathway. In contrast, µ-opioid inhibition of VGCC is not relieved 
by such pre-pulses, indicating a voltage-independent diffusible second-messenger 
signaling pathway. Furthermore, relief of κ-opioid inhibition during a physiological AP 
burst stimulation indicates the possibility of activity-dependent modulation in vivo. 
Differences in the facilitation of Ca2+ channels due to specific G-protein modulation 
during a burst of action potentials may contribute to the fine-tuning of Ca2+-dependent 
neurotransmitter release in other CNS synapses, as well.   
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Introduction 
 
 The hypothalamic neurohypophysial system (HNS) releases both oxytocin (OT) 
and vasopressin (AVP) neuropeptides into a capillary bed for systemic delivery. Action 
potentials from magnocellular neurons to the neurohypophysial terminals elicit secretion 
of both hormones by triggering the opening of voltage gated calcium channels (VGCC) 
leading to subsequent rise in intraterminal Ca2+ concentration (Bicknell, 1988; Lemos, 
2002). Release from neurohypophysial terminals is very sensitive to intraterminal 
calcium (Dreifuss et al., 1971; Dreifuss and Nordmann, 1974; Bicknell, 1988; Berrino et 
al., 1989; Jackson et al., 1991a; Salzberg et al., 2000; Steffensen et al., 2002). Isolated 
neurohypophysial (NH) terminals show inhibition of VGCC in the presence of either μ-
opioid agonists (Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005) or κ-opioid 
agonists (Rusin et al., 1997b), and inhibition of subsequent release of both oxytocin and 
vasopressin (Sumner et al., 1990; Kato et al., 1992; Russell et al., 1993). The signaling 
mechanism and modulatory importance of μ- and κ-receptor activation at these pre-
synaptic terminals and subsequent VGCC inhibition is still not well understood, however.  
 Endogenous opioids, which are secreted from both the CNS and the 
Neurohypophysis, modulate both OT and AVP secretion from the magnocellular 
neurosecretory system (Douglas et al., 1995a; Elhamdani et al., 2000). However, 
modulation via μ- and κ-opioids is neither identical nor static and displays plasticity in 
response to changes in physiological status. Co-release of dynorphin, an endogenous κ-
opioid agonist, with vasopressin from magnocellular neuron cell bodies and dendrites has 
been shown to facilitate activity-dependent modulation of vasopresinergic neurons 
 79
(Bourque et al., 1998; Brown and Bourque, 2004; Brown et al., 2004; Roper et al., 2004; 
Brown et al., 2006; Sabatier and Leng, 2007).  κ-opioid receptors have also been found in 
isolated terminals of the Neurohypophysis (Hamon and Jouquey, 1990; Smith et al., 
1993).  In non-synaptic structures, activation of κ-opioid receptors reduces post-spike 
depolarizing after-potentials decreasing the spontaneous firing rate of magnocellular 
neurons in-vitro and subsequent transmitter release (Inenaga et al., 1994; Brown et al., 
1999; Brown and Leng, 2000). Endogenous μ-opioid effects are associated with their 
predominant role in inhibition of oxytocin cells during pregnancy (Russell et al., 2003). 
The μ-opioid inhibition of the magnocellular neurosecretory becomes increasingly 
evident during pregnancy, but is subsequently interrupted prior to parturition allowing 
strong excitation of oxytocin cells and thus facilitates birth (Russell et al., 1995b; Russell 
et al., 2003). 
 Peak release efficiency for both oxcytocin and vasopressin is achieved via 
specific bursting modes of activity of magnocellular neurons (Bicknell and Leng, 1981; 
Poulain and Wakerly, 1982). Oxcytocin release is optimum during high frequency firing 
and vasopressin release is facilitated via an asynchronous bursting firing pattern. 
Frequency variations within a train of action potentials is a key component of both types 
of physiological bursts (Cazalis et al., 1985; Bicknell et al., 1988). Various possible 
explanations for this phenomenon have been proposed. Since repetitive firing produces 
broadening of action potentials, action potential broadening and subsequent buildup of 
residual calcium, have been proposed to explain the frequency dependence of both AVP 
and OT release (Leng and Shibuki, 1987; Muschol and Salzberg, 2000). However, a yet 
unexplained residual frequency-dependent facilitation of action potential-induced rise in 
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the intracellular Ca2+ concentration [Ca2+]i, unrelated to action potential broadening, 
remain to be explained (Jackson et al., 1991b). Furthermore, biophysical properties of the 
VGCC present in isolated terminals cannot account for the observed frequency-dependent 
facilitation (Wang et al., 1997a; Wang et al., 1999b; Lemos and Wang, 2000b). Persistent 
baseline release of AVP with its concurrent co-release of dynorphin (Bourque et al., 
1998; Brown and Bourque, 2004; Brown et al., 2004; Roper et al., 2004; Brown et al., 
2006; Sabatier and Leng, 2007), and its documented effects on action potential duration, 
post-spike excitability and reduced stimulated neuropeptide release  (Inenaga et al., 1994; 
Brown et al., 1999; Brown and Leng, 2000), could represent a tonic inhibitory regulation 
of both OT and AVP release. We propose that voltage-dependent relief of tonic κ-opioid 
mediated inhibition of VGCC may help explain the importance of specific frequency-
dependent bursting patterns in increasing efficacy of neuropeptide release. 
 Both the μ- and κ- receptors are G-protein coupled receptors can potentially 
mediate their inhibitory effects on VGCC through either a membrane-delimited or 
diffusible second-messenger pathway (Wilding et al., 1995; Kaneko et al., 1998; Soldo 
and Moises, 1998; Connor and Christie, 1999; Chen et al., 2000). A membrane-delimited 
pathway is described as G-protein activation leading to βγ subunits directly associating 
with a voltage-gated calcium channel and typically inhibiting calcium currents. This 
association is described as voltage-dependent and characterized by a slowing of 
activation kinetics of the currents, as well as attenuation of the response when preceded 
by a depolarizing pre-pulse (Dolphin, 1996; Tedford and Zamponi, 2006). As the term 
implies, all signaling components are associated with the membrane. During classic 
whole-cell patch-clamp recordings, inhibition of VGCC via a G-protein membrane-
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delimited pathway should be observable whether using classic or the perforated-patch 
configuration. In contrast, a voltage-independent inhibition typically involves signaling 
via a diffusible second-messenger and can be blocked by intraterminal dialysis as occurs 
during classic whole-cell patch-clamp in HNS terminals. This inhibition may only be 
observed in calcium currents recorded using the perforated-patch configuration of whole-
cell patch clamp, as is the case for μ-opioid inhibition of calcium currents in the HNS 
(Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005) but not for κ-opioid inhibition 
(Rusin et al., 1997b). 
 The μ- and κ-opioid receptors are heterotrimeric G-protein coupled receptors, 
capable of interacting with either pertussis toxin-sensitive and pertussis toxin–insentive 
G-proteins (Connor and Christie, 1999). N-ethylmaleimide (NEM), a sulfhydryl 
alkylating reagent, has been characterized as a blocker of specific G-protein ADP-
rybosylation, which results in termination of downstream opioid receptor signaling 
initiated by agonist binding (Ueda et al., 1990; Ueda et al., 1996). Studies show that 
treating membranes with NEM abolishes signaling downstream of G-protein activation 
by the κ-opioid agonist U50488 and μ-receptor agonist DAMGO (Allgaier et al., 1989; 
Ueda et al., 1990; Ofri and Simon, 1992; Ueda et al., 1996).   
 G-protein membrane-delimited inhibition can be relieved by pre-pulse 
depolarization in a voltage-dependent manner. Similarly, voltage-dependent disinhibition 
of calcium currents via a simulated physiological burst of action potential waveforms 
(APWs) can induce activity-dependent synaptic facilitation underlying a form of short-
term plasticity in vivo, which can presumably enhance neurotransmitter release (Currie 
and Fox, 2002; McDavid and Currie, 2006). The ability of action-potential-like 
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waveforms (APWs) to attenuate opioid-induced inhibition of VGCC has been shown in 
the NG108-15 cell line (Tosetti et al., 1999). Their results suggest that neuronal firing 
may relieve opioid inhibition of calcium currents in a frequency-dependent manner. In 
the present study we have looked at the voltage- and frequency-dependent inhibition of 
calcium currents by both the μ- and κ-opioid receptors in isolated HNS terminals. These 
calcium currents were elicited by both rectangular-pulses and APW stimulations and 
facilitation was induced utilizing varying rectangular depolarizing pre-pulses. 
Furthermore, we have studied relief of opioid inhibition on APW-elicited calcium 
currents during a simulated physiological burst of APWs.  
 
Materials and Methods 
 
Isolation of nerve endings: 
Male Sprague-Dawley rats (Taconic Farms, Germantown, NY) weighing 200–250 
g were sedated using CO2 and immediately decapitated. The neurohypophysis was 
isolated as previously described (Lemos and Nordmann, 1986; Knott et al., 2002). 
Briefly, following removal of the anterior and intermediate lobes, the neurohypophysis 
was homogenized in 270 μl of buffer at 37oC containing (in mM): 270 sucrose, 0.004 
EGTA, 10 HEPES-Tris, buffered at pH 7.25; 298–302 mOsmol/L. The solution 
containing the homogenate was plated on a 35 mm petri dish and carefully washed in 
Low-calcium Locke’s solution which consists of modified Normal Locke’s (in mM): 145 
NaCl, 2.5 KCl, 10 HEPES, 1.2 glucose, 0.8 CaCl2, 0.4 MgCl2, pH 7.4; 298–302 
mOsmol/L.  
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 Electrophysiological experiments: 
The neurohypophysis was isolated and homogenized as previously described 
(Brethes et al., 1987; Brown et al., 2006).  Current recordings were obtained using the 
perforated-patch configuration on isolated HNS terminals. Using an inverted microscope 
the terminals were identified visually by their characteristic appearance, spherical shape, 
lack of nuclei, and size (5–10 μm in diameter). The pipette solution consisted of (in mM): 
145 Cs-gluconate, 15 CsCl, 2 MgCl2, 2 NaCl, 7 Glucose, 10 HEPES (pH 7.3), at 295 
mOsm. Amphotericin B at a concentration of 30 μM (SIGMA) was added as a 
perforating agent. The bath solution consisted of (mM): 145 NaCl, 5 KCl, 1 MgCl2, 10 
HEPES, 10 Glucose, 1.2 CaCl2, pH 7.5 (Normal Locke’s solution).  In all experiments 
TTX (100 nM) was added to the bath to block sodium influx via voltage-gated sodium 
channels. The pipette resistance was 5-8 MΩ. Pipettes were made of thin borosilicate 
glass (Drummond Scientific Co., Broomall, PA, USA). After perforation the terminals 
were voltage-clamped at –80 mV. Depolarization was applied every 30 seconds to 0 mV 
for 250-300 ms. The preparation was either continually perfused, via a gravity driven 
perfusion, or left in a static non-perfused bath (as noted). Agonists and antagonists were 
either applied through the gravity driven perfusion system, or added to the static bath. All 
experiments were performed at room temperature (25oC). Data was acquired, stored and 
analyzed using a Pentium I computer (Gateway) and pClamp 7 (Axon Instruments, Foster 
City, CA). Currents were corrected online using an inverted P/4 protocol. All time 
constants (τ’s) were obtained using a single exponential curve fit (Igor, Wavemetrics) on 
inward calcium currents. For the rise times (activation), the fit was made between 2 ms 
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after start of stimulus (in order to avoid transient artifacts) and 2 ms before peak (since 
between this period and peak time the “shape” of the segment is not a simple 
exponential). For calcium currents elicited by action potential waveforms, the time of 
peak was measured from the beginning of the waveform to the maximum inward currents 
(in conditions where the sodium current was blocked). 
Stimulus-induced (0.3 to 0.4 ms duration, 5-10 nA) action potentials (APs) were 
recorded from isolated neurohypophiseal terminals using the perforated-patch method 
and the fast current-clamp mode of an EPC9 amplifier (HEKA Instruments) in the 
absence of voltage-gated channel blockers. The APs were used as waveforms for voltage 
commands in voltage clamp mode on subsequent experiments with isolated terminals, 
also using the perforated-patch method. Action potentials from isolated terminals show 
frequency-dependent broadening (modulation). Inherent changes in rise time occur 
concomitant with AP broadening which are reflected in the APWs tested. Broadening 
was induced by repetitive stimulation (30 Hz or more, the plateau for broadening is 
reached at 10 Hz) at frequencies within known physiological conditions. Since action 
potentials were recorded independently, waveforms composed of bursts of modulated 
action potential (trains) were constructed artificially by joining successive action 
potentials (concatenating). In this manner, a burst consisting of gradually broadening 
action potentials (from initially-fastest to finally-slowest) was constructed having 
frequency characteristics within those observed physiologically.  
 
 
 
 85
Statistical comparisons.  
In all cases, data are reported as mean ± SEM; n being the number of terminals. 
Statistical analysis of difference was made with paired t-test, with p< 0.05 considered 
significant.  
 
Results 
 
G-protein mediated inhibition by U50488: 
 Ca2+ channel inhibition in isolated HNS terminals by κ-opioid receptor agonists, 
including U50488, has been previously shown using the “classic” whole-cell patch 
configuration (Rusin et al., 1997b) and now confirmed using the perforated-patch clamp 
mode (Fig. 3.1A). The perforated-patch configuration of the whole-cell patch-clamp 
method is typically utilized to prevent intracellular dialysis of diffusible components. The 
results show that current  inhibition by κ-receptor agonists can be observed with (Rusin et 
al., 1997b) or without intraterminal dialysis of diffusible components. In contrast current  
inhibition by the μ-opioid agonist DAMGO can be observed only using the perforated-
patch configuration (Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005). 
 In order to link μ- and κ-receptor inhibition of calcium currents to the activation 
of a G-protein coupled receptor by DAMGO (100 nM) and U50488 (100 nM), we tested 
both by pre-treating the terminals with 10 μM NEM for 5 min.  Functional studies of 
opioid receptor cysteine residues show that agonist binding to the receptor itself is not 
likely to be affected at 5-10 μM concentrations of NEM (Ueda et al., 1996; Ehrlich et al., 
1998). This concentration was sufficient to block all κ- and μ-opioid inhibition of 
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calcium currents (Fig. 3.1B-C) demonstrating that these responses are via a G-protein 
mediated pathway, potentially pertussis toxin-sensitive. Pertussis toxin could not be used 
given the necessity for long incubation periods that are incompatible with the lifetime of 
our isolated HNS preparation. Therefore, we have characterized the biophysical 
differences of the two pathways instead. 
Voltage-dependent inhibition is also characterized by a slowing of current 
activation kinetics. Activation time constants were measured for rectangular pulse-
elicited total calcium currents under control conditions and in the presence of either 100 
nM U50488 or 100 nM DAMGO. Activation of total calcium currents includes 
contributions from VGCC such as the N-, L-, R- and Q-type (Wang et al., 1997c; Wang 
et al., 1999b). The time for an e-fold change (τ) of activation kinetics was measured in 
the presence of either κ- or μ-opioid agonists and divided by that of the control (no 
opioid).  This was done in order to account for the variability of the measured time 
constants between samples (n =8). The ratio is expressed as a percentage difference from 
100% (i.e., 0% difference = no change, negative % difference = faster time constant, and 
positive % difference = slower time constant). Results show a 75 ± 44.2 % difference for 
U50488 and only a 1.7 ± 11.3 % difference for DAMGO. Slower activation kinetics 
during κ-opioid inhibition of calcium currents concurs with the idea that κ-opioid 
inhibition of VGCC in the HNS terminals is mediated via a membrane-delimited 
pathway.  
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Voltage-dependent vs. Voltage-independent inhibition of VGCC via μ- and κ- opioid 
agonists: 
 Given the resistance of κ-opioid inhibition to intraterminal dialysis we 
hypothesized that κ- not μ-opioid inhibition would be voltage-dependent. We tested for 
voltage-dependent inhibition by using a depolarizing pre-pulse (DPP) protocol on 
rectangular pulse-elicited Ca2+ currents. When such calcium currents are preceded within 
2-4 ms by a DPP consisting of a voltage jump from –80 mV to +100 mV with 30 ms 
duration, U50488 inhibition was completely blocked (Fig. 3.2A). DAMGO inhibition, 
however, was unaffected (Fig.3.2B). The depolarizing pre-pulse had no effect on control 
calcium currents without opioid treatment or during NEM treatment (data not shown). 
Given that short exposures of NEM may selectively block PTX-sensitive G-proteins, as 
observed in SCG neurons, it’s important to note that PTX-sensitive G-proteins have been 
shown to mediate voltage-dependent, membrane-delimited processes (Zong et al., 1995; 
Yassin et al., 1996; Jeong et al., 1999).  Therefore, results indicate that κ- but not μ-
opioid inhibition is voltage-dependent. 
  
DAMGO and U50488 inhibition of APW elicited calcium currents: 
 As mentioned above, endogenous opioids secreted from both the CNS and the 
Neurohypophysis, modulate both OT and AVP secretion from the magnocellular 
neurosecretory system (Douglas et al., 1995a; Elhamdani et al., 2000). However, calcium 
currents in-situ are not elicited by rectangular depolarizing pulses but by action potentials 
(APs). APW-elicited Ca2+ currents were thus studied to determine the effects of opioids 
on currents elicited by more physiologically relevant stimuli (See Methods). For tests 
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made with individual APs, four types of APs were chosen such that their degree of 
broadening would represent a sampling of the broadening span during a burst: from peak 
to half amplitude on the falling phase within a range of 1 to 4 ms (Fig. 3.3A). Peak 
calcium currents varied with longer duration APW (Fig.3.3B). The APW calcium 
currents where obtained using 100nM TTX to block all voltage-gated sodium channels 
and with Cs-glutamate in the pipette solution to block all K+ currents. The remaining 
currents were pharmacologically determined to be calcium currents by blocking them 
with 200 μM NiCl2/CdCl2 (Fig. 3.4). Inhibition with either κ- or μ-opioid agonists did 
not significantly change in relation to control currents of equal duration, regardless of the 
APW duration (Fig. 3.4C). Both U50488 (Fig. 3.5A) and DAMGO (Fig. 3.5B) inhibit 
APW-elicited calcium currents (APW duration was 4 ms from peak to half amplitude on 
the falling phase) to a similar extent as those elicited by rectangular pulses. Inhibition, 
expressed as percent of control current without opioid, by U50488 of APW currents (71 ± 
5%) was similar to that of rectangular pulse-elicited currents (73 ± 12%). Inhibition by 
DAMGO of APW currents (77 ± 8%) was also similar to that of rectangular pulse-
elicited currents (75 ± 9 %).  
Voltage-dependent G-protein modulation of Ca2+ currents could be relieved by 
physiologically relevant electrical activity. We thus selected the broadest APW with a 
duration of 4 ms to measure all other effects on U50488 and DAMGO inhibition of APW 
elicited calcium currents. The criterion for selecting the broadest APW was based on 
using an APW that would be most likely at the end of a train of APs (Gainer et al., 1986; 
Leng and Shibuki, 1987; Jackson et al., 1991a; Branchaw et al., 1998; Muschol and 
Salzberg, 2000; Marrero and Lemos, 2005). Presumably, this APW would see a full 
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range of frequencies preceding it and the largest accumulation of endogenous opioids 
throughout a physiological burst (Bicknell et al., 1988; Bourque, 1991; Bourque et al., 
1998).  
To assess voltage-dependent relief of µ- and κ-opioid receptor inhibition of 
voltage-gated Ca2+ channels (VGCC) elicited with a more physiological stimulus, we 
have measured opioid effects on calcium currents elicited by action potential waveforms 
with and without a rectangular DPP. A DPP similar to that applied prior to the 
rectangular test pulse was applied prior to APW elicited currents using a 2 ms interpulse 
interval, a voltage jump to +100 mV (delta +180 mV) and duration of 30 ms (Fig. 3.6). 
All stimulations were measured as percent of control current without treatment. Ca2+ 
current inhibition by U50488 (74.4 ± 39 %) disappeared after DPP (97.6 ± 5.2%) 
whereas Ca2+ current inhibition by DAMGO (88.6 ± 1.9%) increased (75.4 ± 6% after 
DPP) (Fig. 3.6). The reduction in current during DAMGO treatment following DPP is 
likely due to voltage-dependent inactivation of VGCC. To establish optimum conditions 
for quantifying U50488 and DAMGO voltage-dependent inhibition, pre-pulse amplitude, 
duration and the interpulse interval were varied (Fig. 3.7). With a DPP prepulse interval 
of 2 ms and duration of 25 ms, DPP amplitude was varied from –70 mV (were -80 mV is 
no pre-pulse) to +130 mV (delta of 20 mV). Maximum relief of U50488 inhibition was 
achieved at +90 to +130 mV. DAMGO inhibition was at no point relieved and exhibits a 
downward trend indicative of voltage-dependent inactivation. Using fixed amplitude of 
+100 mV (delta of +180 mV) and a 2 ms pre-pulse interval, DPP duration was increased 
from 1 ms to a maximal duration of 104 ms (delta of 13 ms). No relief of U50488 
inhibition occurred with a 1 ms duration DPP. However, following a 13 to 27 ms DPP, 
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inhibition by U50488 decreased and remained attenuated thereafter. In contrast, DAMGO 
inhibition was not attenuated for any of the same DDP durations. Pre-pulses to +100 mV 
(delta of +180 mV) were then used to examine the effect of increasing the interpulse 
interval from 2 to 8 msec. Maximum attenuation of U50488 inhibition was achieved at 2-
4 ms interpulse intervals. These results were used to establish optimum prepulse 
parameters (and those used thereafter, unless otherwise stated) as follows: 2 ms initial 
interpulse interval, amplitude to +100 mV, 30 ms duration, all followed by the broadest 
APW.  Opioid induced inhibition of APW-evoked currents was plotted as a percent of 
control current without opioid (Fig. 3.7). As observed for calcium currents elicited with a 
rectangular pulse, both U50488 (71 ± 5 %) and DAMGO (52.8 ± 9.5 %) inhibition of 
APW-elicited calcium currents were relieved with 10 μM application of NEM (96.1 ± 
3% and 106 ± 10.3 %, respectively) (Fig. 3.8). In contrast, control and NEM treated 
terminals showed no facilitation of APW calcium currents using identical DPP protocols.  
 
Frequency-dependent relief of kappa opioid inhibition  
 Protocols of varying frequency were designed using 1ms duration rectangular pre-
pulses, which, although similar to in vivo AP duration, were ineffective in relieving any 
inhibition (Fig. 3.9A-C). Currents decreased by DAMGO were further decreased 
progressively as DPP frequency increased (Fig. 3.9E). Similar voltage-dependent 
inactivation was observed with control and NEM treated calcium currents (data not 
shown). In contrast, inhibition by U50488 is attenuated (recovery to 100% of control) at 
10 Hz (Fig. 3.9D,E). At 50 and 100 Hz the currents remain significantly different from 
DAMGO but exhibit a similar downward trend. This is probably due to voltage-
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dependent inactivation and could reflect an inherent competing effect with DPP-induced 
relief of voltage-dependent inhibition.  
 As observed in the sample currents in fig. 3.9D, APW-elicited total calcium 
currents in the presence of U50488 show a change in activation kinetics. The time to peak 
of the AWP-elicited calcium current was measured in the presence of either κ- or μ-
opioid agonists and divided by the time to peak in its absence (control). This was done in 
order to account for the variability of the peak times between samples (n =8). The ratio 
was then expressed as a percentage difference from 100% (i.e., 0% difference = no 
change, negative % difference = decrease in time to peak, and positive % difference = 
increase in time to peak). Results show (% ± SEM) 8.8 ± 2.9 % difference for U50488, 
and -3.3 ± 6.7 % difference for DAMGO. The change in activation kinetics of the APW-
elicited current in the presence of U50-488 was smaller than those measured for 
rectangular pulse elicited currents. However, as noted by others (Park and Dunlap, 1998), 
APW-elicited currents have changing and comparatively brief activation phases which 
make kinetics more difficult to quantify and compare.  
   
κ-opioid inhibition relieved by a train of action potentials 
 The effect of action-potential-like waveforms (APWs) on U50488 κ-opioid 
inhibition of voltage-gated Ca2+ channels was investigated using a train of APs (Fig. 
3.10). The Long APW studied is present at the end of the train and compared in and out 
(individual APW) of the context of the burst. Burst-elicited example calcium currents 
under control (black) and opioid (color) conditions are presented in figure 3.11A and 
3.11B. Single Long APW currents are presented under control (no opioid) and treated 
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(either 100 nM U50488 or 100 nM DAMGO) to show inhibition of the currents in the 
same terminal without the burst effects (Fig. 3.12C and 3.12D). In the presence of 
opioids, the currents from several individual APWs of different duration are compared to 
the currents obtained from the same APWs within the simulated burst (Fig. 3.12). This 
comparison was designed to examine the opioid inhibition in and out of the context of the 
burst as a percent of control (single APW of same duration without opioid). U50488 
inhibition was significantly (* p<0.05) relieved within the burst for APs shortly after the 
middle of the burst (AP #26, Fig. 3.12A). DAMGO inhibition was not relieved regardless 
of APW duration or AP position within the burst (Fig. 3.12B). The start of relief of 
U50488 inhibition was observed with 8 APs preceding the APW-elicited current, at an 
average frequency of 100 Hz.   
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 Discussion 
 
 This is the first time, to the best of our knowledge, that κ-mediated inhibition of 
VGCC in the HNS has been shown to be voltage-dependent within a burst of APs. Given 
the importance and ubiquitous nature of κ-mediated inhibition of VGCC in HNS cell 
bodies, dendrites and in terminals, the mechanism of modulation of VGCC as key 
triggers for electrically evoked release is central to understanding some of the pivotal 
events in depolarization-secretion coupling. Furthermore, we have also shown that μ-
opioid receptor inhibition is not voltage-dependent.  
Intraterminal signaling of μ- and κ-opioid receptors in HNS terminals 
The differences in mechanisms for μ- and κ-opioid receptor inhibition of VGCC 
have important physiological relevance. Oxytocin neurons are highly tuned to μ-receptor 
inhibition whereas AVP release is most sensitive to κ-receptor activation (Bicknell, 1985; 
van Wimersma Greidanus and van de Heijning, 1993; Russell et al., 1995a; Brown et al., 
2000a; Russell et al., 2003; Ortiz-Miranda et al., 2005).  In isolated terminals the 
inhibitory constraints of both μ− and κ−opioids are mirrored in the systemic output of 
both vasopressin and oxytocin in response to different physiological needs. The diffusible 
second-messenger pathway mediating μ-opioid inhibition is voltage-independent and 
therefore would remain relatively unaffected throughout the duration of an action 
potential burst (See Chapter IV). Therefore, attenuation of μ-opioid inhibition of Ca2+ 
currents must stem from either lack of agonist interaction with the receptor, receptor 
internalization/desensitization or changes in diffusible second-messenger signaling. 
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These are comparatively long-term changes in the magnocellular (MNC) neurons and 
HNS interactions in contrast to short-term relief of inhibition or facilitation observed 
during voltage-dependent κ−opioid inhibition. Given the necessary long-term inhibition 
of μ-receptors during pregnancy and, in contrast, the short-term synchronization of AVP 
activity for optimum release the transduction mechanisms of the two opioids are perfectly 
suited to modulate their specific neuropeptide target outputs in the system.  
Frequency-dependent facilitation in HNS and the role of voltage-dependent relief of 
κ-receptor inhibition 
Experiments performed on the isolated neurohypophysis have demonstrated that, 
within a certain range, the same number of pulses given at high frequency (50-100 Hz) 
induces the release of a larger amount of neuropeptide than when delivered at lower 
frequency (Dreifuss et al., 1971; Nordmann and Dreifuss, 1972). Oxytocin cells are 
known to fire within the 50-100 Hz range for periods of 0.5-2.5 sec. (Wang and Hatton, 
2005) for optimum neuropeptide secretion (Nordmann and Stuenkel, 1986). AVP 
containing cells, upon physiological demands such as hemorrhage (Poulain et al., 1977) 
or dehydration (Arnauld et al., 1975) change their pattern of firing from slow or tonic to a 
higher frequency phasic firing pattern. The exact reason why specific frequency 
stimulations optimize neuropeptide secretion is still under intense study (Lemos and 
Wang, 2000b). However, we know that appropriate timing of electrical signals is 
important in conveying an accurate physiological response, as with learning and memory 
(D'Angelo and Rossi, 1998; Matsumoto and Okada, 2002; Debanne et al., 2003; 
Thivierge et al., 2007; Caporale and Dan, 2008). Hypothetically, integration of signaling 
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from various sources for optimum response at the presynaptic juncture may require a 
systemic inhibition relieved only by the appropriate timing of electrical input.  
Voltage-dependent relief of κ-receptor inhibition in-situ 
Here we propose that neuropeptide release is potentially tonically inhibited by 
endogenous κ-opioid modulation, until electrical stimuli from MCN facilitates voltage-
dependent relief. Temporal integration of the appropriate signals from MCNs can result 
in high frequency bursting relieving VGCC from tonic voltage-dependent κ-opioid 
inhibition, thus facilitating optimum neuropeptide release (Dyball et al., 1988; Brody et 
al., 1997). This could also allow the terminals to prime release during the initial high 
frequency phase of the action potential burst, by mobilizing readily releasable pools of 
neurosecretory granules (Nowycky et al., 1998). Optimum release would result, during 
the latter part of the burst, from a combination of a larger population of immediately 
releasable granules, broader action potentials, and removal of voltage-dependent VGCC 
inhibition (Andrew, 1987; Leng et al., 1988b; Nowycky et al., 1998; Marrero and Lemos, 
2005). Oxytocin release, would completely bypass any κ-opioid voltage-dependent 
inhibitory constraints on release given its much higher frequency range of stimulation. 
Role of voltage-dependent inactivation  
 Our results show, that unlike rectangular DPPs of varying frequencies, a train of 
APWs is capable of relieving U50488 inhibition at frequencies higher than 10 Hz (Fig. 
3.9). This may be due to APW pulses having comparatively slower activation kinetics 
than rectangular pulses making them capable of unmasking all of the facilitation while 
avoiding the competing accumulation of voltage-induced Ca2+ current inactivation. 
Voltage-dependent Ca2+ current inactivation occurs with all stimulations and could 
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possibly lead to underestimating U50488 facilitation by the DPP. The possibility that the 
Gβγ subunits may actually accelerate inactivation of calcium currents during high-
frequency trains of APW has been proposed (Patil et al., 1998). However, activation of 
endogenous G-proteins has been shown, so far, to reduce both Ca2+-dependent, and 
voltage-dependent inactivation of calcium currents in different expression systems 
(Bourinet et al., 1996; McDavid and Currie, 2006). Although further studies are required 
to determine the nature of the frequency-dependent relief of inhibition, our results 
indicate there is a relationship between frequency and optimum relief from voltage-
dependent κ-opioid inhibition. The optimum frequency-dependent relief is likely a 
function of both Gβγ dissociation from and voltage-dependent inactivation of VGCC. 
AP broadening in HNS terminals 
 Nerve terminals show a progressive broadening of their action potentials when 
elicited repetitively (i.e., within a burst). The degree and rate of broadening is dependent 
on firing frequency (Gainer et al., 1986; Bourque, 1990; Jackson et al., 1991b). We 
simulated burst broadening in our burst pattern and found that disinhibition of κ-receptor 
activation progressively occurs reaching a maximum during the latter part of the burst 
during the broadest APWs. This is consistent with studies done by Brody and colleagues 
(Brody et al., 1997) that show the extent of G-protein disinhibition of P/Q-type calcium 
channels in HEK cells increases linearly with the duration of the action potential 
waveform. Although further investigation is required to determine whether a specific type 
of APW or number of previous depolarizations and/or frequency is best suited for relief 
of voltage-dependent inhibition, we have shown that relief of κ-opioid inhibition of 
VGCC in the HNS is achieved by a physiological burst of action potentials.  
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Conclusion 
The endogenous κ-opioid mediated inhibition of VGCC and its voltage-dependent 
modulation provides the potential for activity-dependent relief of inhibition during action 
potential trains. This physiologically-evoked, activity-dependent modulation of VGCC 
and subsequent release, represents an important mechanism for short-term synaptic 
plasticity at the level of the terminals. Given the ubiquitous nature of voltage-dependent 
G-protein signaling in the CNS, our results may prove important in understanding 
modulatory effects of specific bursting patterns throughout the CNS. 
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Figure 3.1 
 
 
Figure 3.1 N-Ethylmaleimide blocks κ- and µ-receptor mediated inhibition of 
calcium currents. A. Calcium currents of single HNS terminal under control (black), 
100 nM U50488 (blue) and wash (green) conditions using the perforated-patch 
configuration of the whole-cell patch-clamp technique. B. Same terminal under control 
(black) and 10 μM NEM with 500 nM U50488 (blue) and 10 µM NEM with 1 µM 
U50488 (light blue) conditions. C. Bar Graph summarizing average effects of opioids 
on Ca2+ current (ICa) (n=5 U50488, n=3 DAMGO). All currents in the presence of 
NEM were not statistically different from their corresponding control (p>0.05) and all 
currents in the presence of opioid agonists without NEM were statistically different 
from their corresponding control. Asterisks (*) represent statistically significant 
differences, p<0.05.  
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Figure 3.2 
Figure 3.2 DPP relieves κ- but not µ-receptor mediated inhibition of calcium 
currents. A. HNS terminal calcium currents under control (black), with 100 nM 
U50488 (blue) and with a DPP in the presence of 100 nM U50488 (green) conditions. 
B. Calcium currents under control conditions (black), with 100 nM DAMGO (pink) 
and with a DPP in the presence of 100 nM DAMGO (green) conditions. C. Bar graph 
quantifying differences as percent control without opioid or DPP from rectangular 
pulse elicited calcium currents with 100 nM U50488, 100 nM U50488 with DPP, 100 
nM DAMGO and 100 nM DAMGO with DPP. Asterisk (*) show statistical different 
(p=6.15e-5). 
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Figure 3.3 
Figure 3.3 Action Potential Waveforms obtained from NH Terminal 
Action Potentials.  A. Current waveform changes with action potential 
duration (measured from the peak to the half height of the falling phase) 
starting from the shortest recorded APW named SW2 with a duration of 1 
ms followed by two intermediate waveforms M1W2 and M2W2 with 
durations of 2.5 and 3.5 ms respectively to the longest LW2 with a 
duration of 4.5 ms. APWs illustrated have an amplitude of 55 mV and 
rising phase of 3.2 msec.  B. Peak Current normalized to maximum of 
APW-elicited calcium currents without treatment plotted as a function of 
action potential duration. C. Percent Peak control Ca2+ current with either 
κ- or µ-opioid agonist plotted as a function of APW duration. Data points 
represent means of 6 terminals.  
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Figure 3.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Currents elicited by Action Potential Waveforms. Currents elicited 
by single action potential waveforms (Waveforms, top blue traces). The internal 
solution contained excess Cs+  (145 mM) in order to block outward potassium 
current components. The APW’s were artificially constructed to simulate action 
potentials for the same types and broadening (order of magnitude) as that observed 
in isolated terminals. The half-time (as measured from the top peak) was 0.85 and 
4.6 ms (top left and right traces, respectively). Inset shows the elimination of 
elicited calcium currents by 200 µM Cd+2/Ni+2 (blow up of rightmost record).  
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Figure 3.5 
 
Figure 3.5 κ- and µ-opioid receptor activation similarly inhibits APW- and rectangul
μ-opioid inhibition belong to the same terminal which is different from that used to test 
κ-opioid inhibition. 
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Figure 3.6 
Figure 3.6 APW-elicited Calcium Currents are also relieved by DPP of κ- but not 
µ-opioid inhibition. Sample APW-elicited calcium currents in two different terminals 
with control (black), or in the presence of their respective opioid agonist, 100 nM κ-
opioid agonist U50488 (blue) (A), and µ-opioid agonist DAMGO (pink) (B), after a 
depolarizing pre-pulse. C. Bar graph quantifying the effects of a DPP on κ- and µ-
opioid inhibition of APW elicited calcium currents. Asterisks (*) represent statistically 
significant difference (p<0.03).  
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Figure 3.7 
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Figure 3.7  Optimizing DPP for APW calcium currents. Opioid induced inhibition 
of APW-evoked currents plotted as a function of pre-pulse (A.&D.) AMPLITUDE, 
(B.&E.) DURATION, and (C.&F.) INTERPULSE INTERVAL. Voltage commands 
are shown in top panel. Fixed prepulse parameters (unless otherwise stated) were as 
follows: 2 ms initial interpulse interval, amplitude to +100 mV (delta of 180 mV), 30 
ms duration, Long waveform stimulation data points in all panels represent the means 
of measurements for 4-5 terminals with their respective SEM. Asterisks (*) represent 
values which are both statistically different from Ca2+ currents with opioid and no 
DPP, p<0.03 and at the same time are not statistically different from control currents 
(without opioid or DPP) p>0.05. 
 
Figure 3.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 NEM relieves both κ- and μ-opioid inhibition of action 
potential waveform elicited Ca2+-currents.
 
 
  Inhibition of the APW-
elicited calcium current with 100 nM U50488 or 100 nM DAMGO was 
not statistically different (p>0.09) nor are both treatments with 5 μM 
NEM significantly different (p>0.19) from each other or from control 
peak currents (n=3 for each). Asterisks (*) represent statistically 
significant differences (p<0.02). 
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Figure 3.9 
 113
 
Figure 3.9 Frequency-dependent relief of κ-opioid inhibition.  Voltage command 
protocols of varying frequency using 1ms duration pre-pulse, stepped to +100 mV and a 2 
ms interval between the last pulse and the Long APW: A. 10 Hz, B. 50 Hz, and C. 100 Hz. 
D. Sample Long AWP elicited calcium currents under control (no opioid, no DPP), 
U50488 after 10 Hz DPP (red), U50488 after 50 Hz (green) and U50488 after 100 Hz 
(purple) DPP protocol. E. Percent of control current without treatment vs. average of 
APW elicited current with 100 nM U50488 (blue), and 100 nM DAMGO (pink). 
Asterisks (*) represent statistically significant p≤0.05 differences between U50488 
treatment and DAMGO. 
 
 
 
 
 
 
 
Figure 3.10 Waveform used for simulating action potential burst (gray). The 
waveform was applied as a relative stimulus (left voltage scale, i.e., depolarizing). 
Darkened segments within the burst waveform indicate action potential equivalents 
to the ones used individually (single action potentials) as designated by the top 
labels (See Fig. 3), with the frequencies that would correspond to their position 
within the burst (Hz, below top labels). The numbers below some of the action 
potentials (between time scale and burst) represent action potentials of a specific 
duration and illustrate their placement within the simulated burst.  
Figure 3.10 
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Figure 3.11 
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Figure 3.11 κ-opioid inhibition of APW calcium currents is relieved within a simulated 
burst. A. Calcium currents elicited by a simulated AP burst under control conditions (black 
line) and in the presence of 100 nM U50488. B. Calcium currents using the same protocol as 
in A. under control (black) or in the presence of 100 nM DAMGO (red). C.&D. Calcium 
currents elicited with a single long APW (LW2) stimulation identical to the one at the end of 
the burst under their respective control conditions (black) or in the presence of 100 nM 
U50488-blue (C) or 100 nM DAMGO-pink (D). Dotted lines are for comparison between 
same opioid modulation of APW-elicited Ca2+-current within (A&B) and outside (C&D) of 
the burst. 
Figure 3.12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 AP-elicited Currents are relieved of κ-inhibition within a Burst. A. Bar 
Graph showing percent of control (currents without κ-opioid agonists elicited with 
identical APW duration as experimental with opioid agonist) during 100 nM U50488 
application on APW-elicited currents of differing durations within the simulated burst 
(dark blue) compared to identical APWs individually elicited Ca2+ currents (light blue). 
B. Bar Graph showing percent of control (currents without μ-opioid agonists elicited 
with identical APW duration as experimental with opioid agonist) during 100 nM 
DAMGO application on APW-elicited Ca2+ currents of differing duration within the 
simulated burst (dark pink) compared to identical APW Ca2+ currents elicited 
individually (light pink). Asterisks (*) represent no statistically significant p>0.5 
difference between treatment (U50488) and control (without opioid) conditions. 
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Abstract 
 
μ-opioid agonists do not inhibit calcium currents when recorded using the classic 
whole-cell patch-clamp configuration (Rusin et al., 1997b). However, μ-receptor 
mediated inhibition of calcium currents is consistently demonstrated using the perforated-
patch configuration (Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005). This strongly 
suggests that the μ-opioid receptor-signaling pathway at the terminals is sensitive to 
intraterminal dialysis and therefore mediated by a readily diffusible second messenger. 
Using perforated patch-clamp technique and ratio calcium imaging methods, we describe 
a diffusible second-messenger pathway stimulated by the μ-opioid receptor that inhibits 
voltage-gated calcium channels (VGCC) in isolated terminals from the Neurohypophysis. 
Our results show a rise in basal [Ca2+]i in response to application of 100 nM DAMGO, a 
μ-opioid receptor agonist, which is blocked by 100 nM CTOP, a μ-opioid receptor 
antagonist. Buffering DAMGO-induced changes in [Ca2+]i with Bapta-AM completely 
blocked the inhibition of both calcium currents and High K+-induced rises in [Ca2+]i due 
to μ-opioid receptor activation. Bapta-AM had no effect on κ-opioid receptor mediated 
inhibition of either calcium currents or High K+-induced rises in [Ca2+]i. Cyclic ADP-
ribose  has been characterized as the endogenous ryanodine receptor agonist (Jin et al., 
2007). Given the presence of ryanodine-sensitive stores in isolated HNS terminals (De 
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Crescenzo et al., 2004b), we tested 8Br-cADP-ribose, a competitive inhibitor of cyclic 
ADP-ribose signaling. 8Br-cADP-ribose partially relieves DAMGO inhibition of calcium 
currents and completely relieves μ-opioid inhibition of High K+-induced rises in [Ca2+]i. 
Furthermore, antagonist concentrations of ryanodine completely blocked μ-opioid 
inhibition of calcium currents and High K+-induced rises in [Ca2+]i while not affecting κ-
opioid mediated inhibition. 100 μM ryanodine also blocked μ-opioid inhibition of 
electrically evoked changes in capacitance. These results strongly suggest that a key 
diffusible second messenger mediating the μ-opioid receptor-signaling pathway at the 
terminals is intraterminal calcium released by cADPr from ryanodine-sensitive stores in 
the isolated HNS terminals. 
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Introduction 
 
 The μ-opioid inhibition of the magnocellular neurosecretory system becomes 
increasingly evident during pregnancy, and is interrupted prior to parturition allowing for 
strong excitation of oxytocin cells and thus facilitating birth (Russell et al., 1995b; 
Russell et al., 2003). Co-release of dynorphin, an endogenous κ-opioid agonist, with 
vasopressin from dendrites facilitates activity-dependent modulation of vasopresinergic 
neurons (Brown and Bourque, 2004; Brown et al., 2004; Roper et al., 2004; Brown et al., 
2006; Sabatier and Leng, 2007). Isolated hypothalamic neurohypophysial (HNS) 
terminals also demonstrate inhibition of release in the presence of either μ- or κ-agonists 
for both oxytocin and vasopressin (Sumner et al., 1990; Kato et al., 1992; Russell et al., 
1993),  VGCC are similarly inhibited (Rusin et al., 1997a; Ortiz-Miranda et al., 2003; 
Ortiz-Miranda et al., 2005). The signaling mechanism and modulatory importance of μ- 
and κ-receptor activation at these pre-synaptic terminals and subsequent VGCC 
inhibition is still not well understood however it will likely prove to be physiologically 
relevant given the importance of endogenous opioid modulation at the level of the cell 
body.  
Both the μ- and κ-opioid receptors are G-protein coupled receptors, which can 
potentially mediate inhibitory effects of opiates on VGCC through either a membrane-
delimited or diffusible second-messenger pathway (Wilding et al., 1995; Kaneko et al., 
1998; Soldo and Moises, 1998; Connor and Christie, 1999; Chen et al., 2000).  The μ-
opioid receptor signaling pathway seems to contrast sharply with that documented for the 
κ-opioid receptor in the same isolated terminals. The first indication of differences in 
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signaling mechanism emerged when it was shown that μ-opioid agonists did not inhibit 
calcium currents when recorded using the classic whole-cell patch-clamp configuration 
(Rusin et al., 1997b). However, μ-receptor mediated inhibition of calcium currents is 
consistently demonstrated using the perforated-patch configuration of the patch-clamp 
method (Ortiz-Miranda et al., 2005). This strongly suggests that the μ-opioid receptor-
signaling pathway at the terminals is sensitive to intraterminal dialysis and therefore 
mediated by a readily diffusible second-messenger. Furthermore, unlike the κ-opioid 
inhibition of VGCC, μ-opioid inhibition is not relieved with a strong depolarizing pre-
pulse (See Chapter III). 
Several diffusible second-messenger pathways can be potential candidates 
mediating μ-opioid inhibition of VGCC in the HNS. Mobilization of internal calcium in 
response to activation of opioid receptors has been well documented in both neuronal and 
non-neuronal systems (for review; Samways and Henderson, 2006). Ryanodine-sensitive 
calcium stores have been shown to be targets of G-protein opioid activation. For 
example, activation of the μ-opioid receptor in isolated mouse astrocytes elicited a 
release of [Ca2+]i blocked by the ryanodine–sensitive antagonist, dantrolene (Hauser et 
al., 1996). In isolated rat ventricular myocytes the rise in [Ca2+]i due to opioid receptor 
activation was blocked when ryanodine-sensitive stores were depleted with ryanodine 
pretreatment (Tai et al., 1992). In isolated HNS terminals we have characterized small 
ryanodine- and voltage-sensitive calcium release events, known as syntillas (De 
Crescenzo et al., 2004b). The cyclic ADP-ribose (cADPr) signaling pathway initiates a 
signaling cascade leading to activation of the ryanodine receptor in-vivo and subsequent 
release of intracellular calcium from ryanodine-sensitive stores (Galione, 1994; 
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Sitsapesan et al., 1995; Morita et al., 2002). Interestingly, recent studies have shown the 
cADPr signaling pathway has a significant role in neuropeptide release from isolated 
HNS terminals (Higashida et al., 2007; Jin et al., 2007). We propose that in HNS 
terminals, activation of the μ-opioid receptor triggers a rise in intraterminal basal 
calcium, released from ryanodine-sensitive stores possibly via activation of the cADPr 
signaling cascade. The rise in [Ca2+]i would lead to calcium-dependent inhibition of 
VGCC and subsequent inhibition of depolarization-induced neuropeptide release. 
 
 
Materials and Methods 
 
Isolation of nerve endings: 
Male Sprague-Dawley rats (Taconic Farms, Germantown, NY) weighing 200–250 
g were sedated using CO2 and immediately decapitated. The pituitary gland was isolated 
as previously described (Lemos et al., 1986; Knott et al., 2005). Briefly, following 
removal of the anterior and intermediate lobes, the posterior pituitary was homogenized 
in 270 μl of buffer at 37oC containing (in mM): 270 sucrose, 0.004 EGTA, 10 HEPES-
Tris, buffered at pH 7.25; 298–302 mOsmol/L. The solution containing the homogenate 
was plated on a 35 mm petri dish and carefully washed in Low-calcium Locke’s solution 
which consists of modified Normal Locke’s (mM): 145 NaCl, 2.5 KCl, 10 HEPES, 1.2 
glucose, 0.8 CaCl2, 0.4 MgCl2, pH 7.4; 298–302 mOsmol/L.  
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Electrophysiological experiments: 
The neurohypophysis was isolated and homogenized as previously described 
(Brethes et al., 1987; Brown et al., 2006).  Current recordings were obtained using the 
perforated-patch configuration on isolated HNS terminals. Using an inverted microscope 
the terminals were identified visually by their characteristic appearance, spherical shape, 
lack of nuclei, and size (5–10 μm in diameter). The pipette solution consisted of (in mM): 
145 Cs-gluconate, 15 CsCl, 2 MgCl2, 2 NaCl, 7 Glucose, 10 HEPES (pH 7.3), at 295 
mOsm. Amphotericin B at a concentration of 30 μM (SIGMA) was added as a 
perforating agent. The bath solution consisted of (mM): 145 NaCl, 5 KCl, 1 MgCl2, 10 
HEPES, 10 Glucose, 1.2 CaCl2, pH 7.5 Normal Locke’s.  In all experiments TTX (100 
nM) was added to the bath to block sodium influx via voltage-gated sodium channels. 
The pipette resistance was 5-8 MΩ. Pipettes were made of thin borosilicate glass 
(Drummond Scientific Co., Broomall, PA, USA). After perforation the terminals were 
voltage-clamped at –80 mV. Depolarization was applied every 30 seconds to 0 mV for 
250-300 ms. The preparation was either continually perfused, via a gravity driven 
perfusion, or left in a static non-perfused bath (as noted). Agonists and antagonists were 
either applied through the gravity driven perfusion system, or added to the static bath. All 
experiments were performed at room temperature (25oC). Data was acquired, stored and 
analyzed using a Pentium I computer (Gateway) and pClamp 7 (Axon Instruments, Foster 
City, CA). Currents were corrected online using an inverted P/4 protocol. All time 
constants (τ’s) were obtained using a single exponential curve fit (Igor, Wavemetrics) on 
inward calcium currents. For the decay time (inactivation) the fit was made between 5 ms 
 123
after peak (to avoid multiple exponentials) and 3 ms before the end of stimulus (to avoid 
transient artifacts).  
 
Calcium imaging 
 Freshly dissociated nerve terminals (Nordmann et al., 1987) prepared from adult 
Sprague-Dawley CD rats were incubated with 2.5 μM Fura-2 AM for 45 min. at 37oC 
and thoroughly washed with Normal Locke’s solution.  Normal Locke’s contained (mM): 
145 NaCl, 5 KCl, 10 Hepes, 10 Glucose, 1 MgCl2 and 2.2 CaCl2, pH 7.4.  Ca
2+ free bath 
solution contained (mM): 145 NaCl, 5 KCl, 10 Hepes, 10 Glucose, 0.0002 EGTA, 1 
MgCl2, pH 7.4, and gave a calculated free [Ca
2+] of zero. Cytosolic [Ca2+] was 
determined with ratiometric indicator fura-2 AM loaded terminals and calibrated utilizing 
an in-vitro calibration kit (Invitrogen, Carlsbad CA).  This was performed according to 
the method of (Grynkiewicz et al., 1985) with an assumed Ca2+-fura 2 KD of 200 nM, as 
previously described (Becker et al., 1989). Resting values for global cytosolic [Ca2+] in 
the presence and absence of extracellular Ca2+ were 73.3 ± 6.9 nM (n = 12) and 46.2 ± 
7.5 nM (n = 8), respectively, and these values demonstrated a statistically significant 
difference (p < 0.05).  In all cases, data are reported as mean ± SEM; n being the number 
of terminals. Statistical analyses of differences were made with paired t-tests, with p < 
0.05 considered significant. 
 Fluorescence images using Fura-2 AM as a calcium indicator were viewed with a 
Nikon Diaphot TMD microscope, using a Zeiss Plan- NEOFLUAR 100X oil immersion 
lens, and fitted with a Photometrics SenSys CCD camera. The camera was interfaced to 
the inverted microscope adapted with a Chroma 71000A Fura2 filter cube. The terminals 
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were excited using a Xenon arc lamp within a Lambda DG4 high-speed filter changer 
(Sutter Instruments Incorporated, Novato,CA) with the appropriate filters (340 and 380 
nm wavelengths). Intraterminal emission of Fura-2 Ca2+ indicator was gathered at 510 
nm wavelength. Fluorescent images were acquired and processed with Axon Imaging 
Workbench 2.1 software (Axon Instruments, Foster City, CA). 
 
Capacitance Measurements 
 Freshly dissociated terminals (Nordmann et al., 1987) from adult adult Sprague-
Dawley CD rats were plated in Normal Locke’s solution with 1.2 mM CaCl2. Tight seal 
“whole terminal” recordings were obtained using the perforated-patch configuration 
described above. The pipettes resistance ranged from 5-8 MΩ. Perforation of the 
terminals’ membrane was obtained by adding 30 μM amphotericin B (SIGMA) to the 
pipette solution containing (mM): 145 Cs-gluconate, 15 CsCl, 5 NaCl, 2 MgCl2, 7 
Glucose, 10 HEPES pH 7.3. The bath solution contained (mM): 145 NaCl, 5 KCl, 1 
MgCl2, 10 HEPES, 10 Glucose, 1.2 CaCl2 or 0.2 EGTA, pH 7.5. Capacitance 
measurements were obtained using the piecewise-linear method (Knott et al., 2007). The 
changes in capacitance induced by a depolarizing pulse (750 ms duration) were measured 
1 second after cessation of stimulus, in order to avoid interference of stimulus “end-tail” 
effects. These stimulus-induced capacitance changes were measured for isolated 
terminals (perforated-patch) using the piece-wise method (Neher and Marty, 1982; 
Lindau and Neher, 1988; Gillis, 1995). Briefly, the method consists in applying a 
sinusoidal voltage of low amplitude to the sample (in order to avoid voltage-elicited 
channel currents) and obtaining the phase shift of the resultant sinusoidal current. 
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Changes in this phase shift (“locked-in”) are used in a formula (computer software that 
emulates a lock-in amplifier) for the determination of the capacitance changes (i.e., the 
capacitance that would cause such change of phase shift). The method is sensitive to very 
small changes in capacitance and, in practice, large baseline capacitance and resistance 
(series) transients must be compensated (i.e., null) before measuring any small 
capacitance change. In this particular case the parameters used were a sine wave of 1000 
Hz at ± 25 mV (about holding potential), with the program reporting a capacitance 
averaged for every 30 points (24 µs sampling rate). The current was filtered at a 
bandwidth of 5000 Hz.   
 
Statistical comparisons.  
In all cases, data are reported as mean ± SEM; n being the number of terminals. 
Statistical analysis of difference was made with paired t-test, with p< 0.05 considered 
significant.  
 
 
Results 
 
μ- but not κ-opioid agonist elicits a rise in basal intraterminal [Ca2+]i  
To determine if intraterminal Ca2+ was part of a diffusible second-messenger 
pathway mediating opioid receptor signaling in isolated HNS terminals, we monitored 
intraterminal calcium in response to μ- and κ-opioid receptor activation. Fura-2 AM ratio 
calcium imaging of isolated HNS terminals has shown a significant inhibition of High 
K+-induced rise in [Ca2+]i when treated with either μ- or κ-agonists (Velázquez-Marrero 
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et al., in preparation; See Chapter III) (Fig.4.1). Furthrmore, pretreatment with 100 nM 
DAMGO (μ-opioid agonist) alone, in 2.2 or 0 mM [Ca2+]o, elicited a rise in basal [Ca2+]i 
(Figs. 4.1 & 4.2). This did not occur when terminals were pretreated with 100 nM 
U50488 (κ-opioid agonist), or puffed with control 0 mM [Ca2+]o Normal Lockes’ (NL) 
(Fig. 4.2A).  Application of 100 nM DAMGO in the presence of the μ-opioid receptor 
antagonist CTOP (Fig. 4.2B) blocked the DAMGO-induced rise in basal [Ca2+]i. Fura-2 
AM calcium measurements were expressed as changes in basal intraterminal calcium 
concentration; 100 nM DAMGO in 2.2 mM [Ca2+]o NL was 26.9 ± 0.8, similar to basal 
changes in 0 mM [Ca2+]o with 100 nM DAMGO (28.7 ± 5.1). Changes in [Ca2+]i due to 
100 nM U50488 were -3.3 ± 5.2, control was -2.4 ± 3.4, and 100 nM DAMGO in the 
presence of CTOP =  -1.8 ± 1.0, all in 0 mM [Ca2+]o. These applications caused an 
artifactual dip in [Ca2+]i which may be inherent factor in all treatment applications and 
could lead to an underestimation of the DAMGO-induced rise in [Ca2+]i.  Baseline [Ca2+]i 
averaged 71.6 ± 15.7 (n=4).  
 
μ- but not κ-opioid inhibition is blocked by intraterminal calcium buffering 
In order to determine if the rise in [Ca2+]i due to μ-opioid agonist application is 
essential for subsequent inhibition of VGCC, we partially buffered [Ca2+]i using Bapta-
AM and monitored the effects on both calcium currents and High K+-induced rise in 
[Ca2+]i. Empirically determined incubation periods of 5-10 min. using low concentrations 
(10 μM) Bapta-AM were followed by a brief wash. Using this procedure Bapta-AM 
buffered DAMGO-induced rises in intraterminal calcium from a 22.7 ± 2.4 nM change in 
[Ca2+]i to 0.2 ± 0.5 nM (Fig. 4.3), but without blocking High K+-induced rise in [Ca2+]i 
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(Fig.4.4). Effects on both High K+-induced rise in [Ca2+]i and calcium currents were 
measured for both μ- and κ-opioid mediated inhibition using the same concentration of 
Bapta-AM for identical incubation periods. All measurements were made as either 
changes in basal [Ca2+]i or percent of control, specifically, control measurements were 
under identical conditions without opioid treatments. Inhibition of High K+-induced rise 
in [Ca2+]i due to 100 nM DAMGO represented 54.1 ± 3.4% of control K+-induced rise in 
[Ca2+]i and 70.9 ± 2.8%  in the presence of 100 nM U50488 (Fig.4.4B). After incubation 
of 10 μM Bapta-AM, terminals exposed to 100 nM DAMGO now showed no inhibition 
(109.9 ± 12.8%) of the High K+-induced rise in [Ca2+]i,  while exposing Bapta-AM 
treated terminals to 100 nM U50488 showed no change in κ-opioid mediated inhibition 
(78.5 ± 2.8%). T-test analysis determined no statistically significant difference (p≥0.3) 
between terminals treated with 100 nM U50488, with vs. without Bapta-AM pre-
incubation. In contrast, there was a statistically significant difference (p≤0.0005) between 
terminals treated with 100 nM DAMGO, with vs. without Bapta-AM pre-incubation 
(Fig.4.4B). Baseline [Ca2+]i without Bapta-AM pre-incubation was 86.5 ± 27.5 nM and 
after pre-incubation with Bapta-AM it was 77.9 ± 12.8 nM. There was no statistical 
difference (p≥0.16) between baseline [Ca2+]i with vs. without 5 min. pre-incubation with 
10 μM Bapta-AM. 
Buffering [Ca2+]i also blocked Inhibition of calcium currents by μ- but not κ-
opioid agonists. Calcium currents treated with 100 nM DAMGO represented 82.2 ± 4.0% 
of control current and 88.7 ± 2.3% in the presence of 100 nM U50488 (Fig. 4.5). After 
pre-incubation with 10 μM Bapta-AM, 100 nM DAMGO treatment now elicited no 
inhibition, with calcium currents 98.9 ± 1.2% of control. Exposing Bapta-AM treated 
 128
terminals to 100 nM U50488, again showed no change in κ-mediated inhibition, with 
calcium currents at 78.8 ± 4.9% of control. T-test analysis determined no statistically 
significant difference (p≥0.09) between terminals treated with 100 nM U50488, with vs. 
without Bapta-AM pre-incubation (Fig.4.5C). There was a statistically significant 
difference (p≤0.001) between terminals treated with 100 nM DAMGO, with vs. without 
Bapta-AM pre-incubation. 
 
8Br-cADP-ribose also blocks μ-opioid inhibition of High K+-induced rise in [Ca2+]i and 
partially relieves μ-opioid inhibition of calcium currents. 
Since the μ-opioid induced rise in [Ca2+]i is essential in mediating μ-opioid 
inhibition, we then wanted to know if the cADPr pathway was part of the receptor 
intraterminal signaling. We therefore, examined the effects of the membrane-permeant 
cADPR antagonist, 8Br-cADP-ribose, on μ-opioid inhibition of both High K+-induced 
rises in [Ca2+]i (Fig. 4.6) and calcium currents (Fig. 4.7). Control High K+-induced 
changes in [Ca2+]i were 457.1 ± 13.5 nM. In the presence of 100 nM DAMGO High K+-
induced change in [Ca2+]i decreased to 392.7 ± 19.6 nM. After incubation with 100 nM 
8Br-cADP-ribose, terminals exposed to 100 nM DAMGO now showed a change in 
[Ca2+]i of 425.9 ± 11.3 nM in response to High K+, similar to those in 100 nM 8Br-
cADP-ribose without DAMGO treatment 427.2 ± 8.9 nM. T-test analysis determined no 
statistically significant difference (p≥0.43) in High K+-induced changes in basal [Ca2+]i  
between terminals treated with 100 nM 8Br-cADP-ribose, with vs. without 100 nM 
DAMGO treatment (Fig.4.6). However, there was a statistically significant difference 
(p≤0.0004) in High K+-induced changes in basal [Ca2+]i  between terminals treated with 
 129
vs. without 100 nM DAMGO, which were not pre-incubated with 100 nM 8Br-cADP-
ribose. Interestingly, baseline [Ca2+]i without 100 nM 8Br-cADP-ribose pre-incubation 
was 79.2 ± 4.0 nM and after pre-incubation with 100 nM 8Br-cADP-ribose was 68.9 ± 
2.8 nM; n=8, and these baselines were statistically different (p≤0.02). 
Inhibition of calcium currents due to 100 nM DAMGO was measured as percent 
of control (Fig. 4.7). As stated above, controls were measurements under identical 
conditions without opioid treatments. Calcium currents treated with 100 nM DAMGO 
represented 76 ± 3% of control current (Fig. 4.7). After pre-incubation with 100 nM 8Br-
cADP-ribose, 100 nM DAMGO treatments now showed a partial relief of inhibition, with 
calcium currents at 90 ± 2% of control. T-test analysis determined there was a 
statistically significant difference between terminals treated with 100 nM DAMGO, with 
or without 100 nM 8Br-cADP-ribose pre-incubation (p≤0.02). 
 
μ-opioid effects are blocked by 100 μM Ryanodine 
We next addressed whether the release of [Ca2+]i due to μ-opioid receptor 
activation was from ryanodine-sensitive intraterminal stores. The pharmacology of the 
ryanodine receptor indicates that 10-100 μM concentrations of ryanodine can block 
ryanodine channel activity (Coronado et al., 1994; Ehrlich et al., 1994).  Therefore, we 
tested the effects of 100 μM ryanodine on DAMGO inhibition of High K+-induced rise in 
[Ca2+]i (Fig. 4.8), calcium currents (Fig. 4.9-4.11), and electrically-induced capacitance 
changes (Fig. 4.10 & 4.11). Control High K+-induced change in basal [Ca2+]i was 219.9 ± 
21.4 nM. In the presence of 100 nM DAMGO High K+-induced change in [Ca2+]i was 
112.7 ± 8 nM which represents 51% of the control response (Fig. 4.8). After incubation 
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with 100 μM ryanodine, terminals exposed to 100 nM DAMGO now showed a change in 
[Ca2+]i of 236.8 ± 8.2 nM in response to High K+, similar to control without DAMGO 
(209 ± 13.4 nM) in the presence of 100 μM ryanodine. T-test analysis determined no 
statistically significant difference (p≥0.11) in High K+-induced changes in basal [Ca2+]i  
between control terminals in 100 μM ryanodine and those in 100 μM ryanodine treated 
with 100 nM DAMGO. There was a statistically significant difference (p≤0.01) in High 
K+-induced changes in [Ca2+]i  between terminals treated with vs. without 100 nM 
DAMGO, which were not pre-incubated with 100 μM ryanodine. Control baseline [Ca2+]i 
was 62.2 ± 11.3 nM and 76.1 ± 11.5 nM after pre-incubation with 100 μM ryanodine; 
(n=3). There was no statistical difference between baseline [Ca2+]i with vs. without 100 
μM ryanodine incubation (p≥0.05). 
Inhibition of calcium currents due to 100 nM DAMGO (Fig. 4.9) was measured 
as percent of control (Fig. 4.11). Calcium currents treated with 100 nM DAMGO were 
inhibited to 76.3 ± 1.8% of control current (Fig. 4.11). During incubation with 100 μM 
ryanodine, calcium currents treated with 100 nM DAMGO showed no significant 
inhibition at 94.6 ± 2.5% of control; (n=6). T-test analysis determined there was no 
statistically significant difference (p≥0.10) between terminals in the presence of 100 μM 
ryanodine with and without 100 nM DAMGO. Inactivation of Ca2+ currents via Ca2+-
dependent inactivation could be reflected in the time constants of inactivation of the total 
recorded currents. We therefore tested the time constants of inactivation of the Ca2+ 
currents under control (no opioid or ryanodine), 100 nM DAMGO, 100 μM ryanodine, 
and 100 μM ryanodine with 100 nM DAMGO conditions (Fig. 4.11). The results were 
plotted as percent control (no opioid or ryanodine). Calcium currents in the presence of 
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DAMGO showed slowed inactivation kinetics resulting in 133 ± 2.6% of control. These 
were statistically different from control values with p≤0.001. In the presence of 100 μM 
ryanodine they were 105.4 ± 3.9%, (statistically not different from control p≥0.77) and in 
the presence of 100 μM ryanodine and 100 nM DAMGO 96.1 ± 3.7% (also statistically 
not different from control p≥0.22; (n=3).  
Reduction of depolarization-induced neuropeptide release is presumably due to μ-
opioid receptor inhibition of VGCC. If μ-opioid inhibition of VGCC can be blocked by 
100 μM ryanodine can we also block the μ-opioid reduction in neuropeptide release? To 
address this question we monitored changes in neuropeptide release reflected as 
capacitance changes in individual terminals (See Methods). Changes in capacitance in 
perforated-patched isolated HNS terminals in response to rectangular pulse 
depolarizations are inhibited by 100 nM DAMGO (Fig. 4.10). The inhibition is almost 
completely reversed by 100 nM CTOP (data not shown) indicating it is mediated by 
activation of the μ-opioid receptor. In the presence of 100 nM DAMGO capacitance 
changes were 43.8 ± 8.2% of control without DAMGO (Fig. 4.10 & 4.11). When 
incubated in 100 μM ryanodine, capacitance changes returned to 102.9 ± 3.5% of control.  
Application of 100 nM DAMGO in the presence of 100 μM ryanodine resulted in 98.2 ± 
2.7% of control capacitance change and was statistically no different than control 
(p≥0.99) or capacitance changes in the presence of 100 μM ryanodine alone (p≥ 0.16). T-
test analysis determined there was a statistically significant difference between terminals 
with vs. without 100 nM DAMGO (p≤0.001) that were not treated with 100 μM 
ryanodine. 
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 Discussion 
 
In the present study we have found that in isolated HNS terminals activation of 
the μ-opioid receptor elicits release of intraterminal Ca2+ from ryanodine-sensitive stores. 
Results show that μ-opioid inhibition of calcium currents and High K+-induced rise in 
[Ca2+]i can be blocked in the presence of antagonist concentrations of ryanodine and 
reduced by competitive inhibition of the cADPr pathway. Changes in the inactivation 
kinetics of calcium currents in the presence of μ-opioid agonists suggests that release of 
intraterminal Ca2+ can be responsible for Ca2+-dependent inactivation of VGCC. 
Furthermore, μ–opioid inhibition of neuropeptide release from individual terminals can 
also be blocked in the presence of antagonist concentrations of ryanodine. The evidence 
supports the hypothesis that μ-opioid receptor activation leads to release of Ca2+ from 
ryanodine-sensitive stores possibly via activation of the cADPr pathway leading to Ca2+-
dependent inactivation of VGCC and subsequent inhibition of DSC. 
μ-opioid effects on the magnocellular neurosecretory system 
Endogenous opioids play an important part in modulation of neuropeptide 
secretion from magnocellular neurons in the neurohypophysis (Clarke et al., 1979; 
Bicknell and Leng, 1981; Clarke et al., 1981; Bicknell et al., 1985b; Nordmann et al., 
1986a; Bondy et al., 1988). Isolated HNS terminals show a reduction in depolarization-
induced release of both OT and AVP in response to both μ- (Zhao et al., 1988b; Leng et 
al., 1992; Russell et al., 1995a; Ortiz-Miranda et al., 2003; Ortiz-Miranda et al., 2005) 
and κ-opioid (Bicknell et al., 1988; Bondy et al., 1988; Zhao et al., 1988a; Rusin et al., 
1997b) receptor activation.  
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cADPr pathway and ryanodine-sensitive stores in HNS terminals 
Oxcytocin secretion is most sensitive to μ-opioid inhibition (Wright and Clarke, 
1984; Bicknell et al., 1985a; Zhao et al., 1988b; Leng et al., 1992; Russell et al., 1995a; 
Ortiz-Miranda et al., 2005). AVP release, while responsive to μ-opioid inhibition, is less 
sensitive to lower concentrations of agonists (Ortiz-Miranda et al., 2003). Interestingly, in 
HNS terminals, blocking cADPr signaling was shown to attenuate High K+ induced rise 
in [Ca2+]i and oxcytocin release from isolated terminals (Higashida et al., 2007; Jin et al., 
2007). This strongly suggests that the cADPr pathway is present in OT terminals were μ-
opioid inhibition is most sensitive. However, the contribution of the cADPr pathway to 
the depolarization-induced response seems to contradict the current results showing 
inhibition by μ-opioid agonist mediated, at least partially, via the cADPr pathway.  
There are some important considerations, which must be addressed in order to 
interpret our current results. First, the concentration of 8-br cADPr in our study is 100 
nM as compared to 100 μM used in previous studies (Jin et al., 2007). Preliminary 
calcium imaging results done in our laboratory on rat isolated HNS terminals, shows a 
significant rise in basal [Ca2+]i in the presence of 100-300 μM concentrations of 8-Br 
cADPr. This would theoretically have the same effects as those seen for μ-opioid agonist 
activation, leading to subsequent calcium-dependent inactivation of VGCC and 
attenuated neuropeptide release. Second, in murine HNS terminals “syntillas”, are both 
ryanodine- and voltage-sensitive (De Crescenzo et al., 2004b; De Crescenzo et al., 2006). 
Syntillas result from the activation of both ryanodine-receptor (RyR) type-1 and type-2 
receptors. Presumably, the type-1 RyR confers the voltage-sensitivity via direct 
interaction with VGCC (De Crescenzo et al., 2006), as documented in skeletal muscle 
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(Schneider and Chandler, 1973; Inui et al., 1987). Inhibition of voltage-dependent release 
of calcium from ryanodine-sensitive stores may account for the inhibition of 
depolarization-induced rise in [Ca2+]i and oxytocin release observed in the presence of 
100 μM ryanodine as previously published (Jin et al., 2007). However, unlike murine 
hypothalamic nerve terminals, chromaffin cells do not display syntilla activation by 
depolarization of the plasma membrane, nor do they have type 1 RyRs (ZhuGe et al., 
2006). Furthermore, it has yet to be determined if ryanodine-sensitive stores in rat HNS 
terminals are voltage-sensitive.   
μ-opioid effects on the inactivation kinetics of calcium currents 
Calcium-dependent inactivation of VGCC is present in HNS terminals (Branchaw 
et al., 1997; Wang et al., 1999b). By saturating the calcium-dependent inactivation, μ-
opioid inhibition of VGCC results in less measurable inactivation of calcium currents 
after a stimulation pulse.  In our current model, release of calcium from ryanodine-
sensitive stores leads to calcium-dependent inactivation of VGCC. Therefore, the lack of 
the Ca2+-dependent component of inactivation during depolarization results in the slower 
rate of the remaining fraction of inactivation observed in the presence of μ-opioid agonist 
(Fig. 4.11C). 
Conclusion 
 Amplification of μ-opioid receptor activation via cADPr-mediated release of Ca2+ 
from a ryanodine-sensitive signaling cascade seems well suited for regulating OT release 
in a voltage-independent manner, during the relatively long period of gestation. It is 
during this time that endogenous μ-opioid inhibition of OT release accumulates to be 
interrupted during parturition and subsequent lactation (Russell et al., 1989; Douglas et 
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al., 1995b; Russell et al., 1995a; Ortiz-Miranda et al., 2003). While inhibition of VGCC 
may only be one possible role for ryanodine-sensitive stores in HNS terminals, it is 
consistent with its effects on VGCC in cardiac (Schneider and Chandler, 1973; Inui et al., 
1987) and skeletal muscle (Fabiato, 1985; Carl et al., 1995; Sun et al., 1995). Opioid-
receptor induced Ca2+ mobilization has also been observed in both mouse astrocytes 
(Hauser et al., 1996) and isolated rat ventricular myocytes (Tai et al., 1992). Intraterminal 
calcium release and its associated Ca2+ microdomains likely have a wide range of 
possible targets and subsequent effects on depolarization-secretion coupling (Berridge, 
2006; Oheim et al., 2006). Therefore, ryanodine-sensitive stores in HNS terminals may 
prove to be bimodal regulators of release depending on the physiological context. Given 
the emerging role of ryanodine-sensitive stores and the cADPr-signaling pathway in the 
CNS, our results may prove important in understanding their physiological role in 
presynaptic structures during depolarization-secretion coupling. 
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Figure 4.1 
 
 
Figure 4.1 μ-opioid agonist triggers a rise in basal [Ca2+]i preceding μ-opioid 
inhibition of High K+-induced rise in [Ca2+]i. A. Images of Fura-2 AM loaded 
single terminal approx. ten seconds apart challenged with High K+ in 2.2 mM [Ca2+]o 
for 5 sec. with and without 100 nM DAMGO. B. Plot of changes in [Ca2+]i over time 
of a different single isolated HNS terminal loaded with Fura 2 AM. High K+ (yellow-
bar) exposures for 5 sec. and DAMGO (dark pink-bar) pretreatment for 10 sec. 
followed by High K+ in the presence of 100 nM DAMGO (red-bar). 
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Figure 4.2 
Figure 4.2 Only μ-opioid agonist triggers release of calcium from 
intraterminal stores. A. Change in [Ca2+]i of isolated HNS terminals in 0 
mM [Ca2+]o in response to 100 nM U50488 (blue), 100 nM DAMGO 
(dark pink), and control treatment containing modified Normal Locke’s 
without Ca2+ (cream); n=5. B. Rise in [Ca2+]i due to 100 nM DAMGO 
application (blue) is blocked in the presence of 100 nM CTOP (dark 
pink); n=4. Asterisks (*) represent statistical differences (p<0.002). 
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Figure 4.3 
 
 
Figure 4.3 Rise in basal [Ca2+]i due to μ-opioid agonist is blocked 
when pre-incubated with Bapta-AM. Bar graph of percent increase of 
[Ca2+]i increase above baseline in the presence of 100 nM DAMGO with 
and without, a 5 min. pre-incubation with 10 μM Bapta-AM, in 2.2 mM 
[Ca2+]o. Pre-incubation with Bapta-AM completely blocks the rise in basal 
[Ca2+]i due to μ-opioid agonist. Asterisk (*) represents statistical 
difference (p<0.004) between 100 nM DAMGO and 100 nM DAMGO 
pre-treated with 10 μM Bapta-AM (n=3). 
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Figure 4.4 
Error! 
Figure 4.4 Bapta-AM relieves μ- but not κ-opioid mediated inhibition of High 
K+-induced rise in [Ca2+]i. A. Plot of changes in [Ca2+]i of a single HNS terminal 
loaded with Fura-2 AM, with and without a brief 10 μM Bapta-AM pre-incubation, 
treated with High K+, and High K+ with 100 nM DAMGO in Normal Locke’s 
solution. B. Bar graph quantifying changes in [Ca2+]i in response to High K+, and 
High K+ with 100 nM DAMGO or 100 nM U50488 with and without Bapta-AM 
pre-incubation (n=4). Asterisk (*) represents statistically significant differences 
(p<0.001). 
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Figure 4.5 
 
 
 
C. 
Figure 4.5 Bapta-AM pre-incubation relieves μ- but not κ-opioid inhibition of 
calcium currents. A. Sample calcium currents of isolated HNS terminal; control 
currents (blue), 100 nM DAMGO (red), and wash (green). B. The same isolated HNS 
terminal with the control pre-incubated in Bapta-AM (blue) trace compared to trace pre-
incubated in Bapta-AM with 100 nM DAMGO (red), and wash (green). C. Bar graph 
quantifying peak barium currents (n=4) as percent of control current without opioid. 
Asterisk (*) represents statistically significant differences (p<0.001). 
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Figure 4.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 cADPr antagonist relieves μ-opioid mediated inhibition of High K+-
induced rise in [Ca2+]i. A. Images of Fura-2 AM loaded single HNS terminal approx. 
ten seconds apart challenged with High K+ in 2.2 mM [Ca2+]o for 10 sec. with and 
without 100 nM DAMGO and with and without pretreatment with 8 Br-cADPr. B. Bar 
graph of change in [Ca2+]i in response to High K+ challenge with and without 100 nM 
DAMGO and with and without incubation with 100 nM 8Br-cADPr (n=8 each). 
Asterisk (*) represents statistically significant differences (p≤0.0003). 
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Figure 4.7 
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Figure 4.7 cADPr antagonist partially relieves μ-opioid inhibition of 
calcium currents. Bar graph quantifying the peak barium currents (n=5), 
as percent of control current without DAMGO. Calcium currents with 100 
nM DAMGO (pink-bar) and with 100 nM DAMGO pre-incubated with 100 
nM 8Br-cADPr (dark pink-bar). Asterisk (*) represents statistically 
significant differences (p<0.02). 
 
Figure 4.8 
 
 
Figure 4.8 Ryanodine antagonist relieves μ- but not κ-opioid mediated 
inhibition of High K+-induced rise in [Ca2+]i. A. Trace of changes in [Ca2+]i 
of a single HNS terminal with and without 100 μM ryanodine incubation 
treated with High K+, and High K+ with 100 nM DAMGO. B. Bar graph 
quantifying changes in [Ca2+]i in response to High K+, and High K+ with 100 
nM DAMGO or 100 nM U50488, with and without 100 μM ryanodine (n=7). 
Asterisk (*) represents statistically significant differences (p<0.001). 
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Figure 4.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Ryanodine antagonist relieves μ-opioid inhibition of calcium 
currents. A. Sample calcium currents of isolated HNS terminal; control currents 
(black), 100 nM DAMGO (pink), and wash (green). B. The same isolated HNS 
terminal with the wash (green) trace compared to a current trace in 100 μM 
ryanodine (black), and 100 μM ryanodine with 100 nM DAMGO (yellow). 
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Figure 4.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Ryanodine antagonist relieves μ-opioid inhibition of depolarization-
induced exocytosis.  Capacitance measurements of single terminal in the absence (red) 
and presence (black) of 100 nM DAMGO, in the presence of 100 μM ryanodine (green), 
and of 100 μM ryanodine and 100 nM DAMGO (blue) using a square pulse of 80 mV 
for a duration of 750 ms. Inset shows the currents obtained from the actual stimulus 
(same color indicators). The generalized conductance changes (“G”) are shown for 
reference. Dashed gray lines represent the zero-change baselines. Peak capacitance 
measurements in the presence of DAMGO were statistically significantly different from 
all other treatments (p<0.002; n=5). 
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Figure 4.11 
Figure 4.11 Summary of ryanodine antagonist effects on μ-opioid inhibition. A. 
Bar graph quantifying changes in stimulus-induced capacitance (n=3) with 100 μM 
ryanodine (dark red), 100 nM DAMGO (pink), and 100 μM ryanodine with 100 nM 
DAMGO (orange), plotted as percent of control without treatment. B. Bar graph 
quantifying peak calcium currents (n=5) as percent of control peak current without 
treatment (same color indicators). C. Bar graph quantifying the inactivation time 
constants of calcium currents (n=5) as percent of control inactivation time constant 
without treatment (same color indicators). Asterisks (*) represent statistically 
significant differences (p<0.009). 
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Chapter V 
 
 
General Discussion 
For the past twenty years the Hypothalamic-Neurohypophysial System (HNS) has 
advanced our knowledge of the basic principles underlying depolarization-secretion 
coupling (DSC). The work presented in this thesis aims to expand our current 
understanding of the underlying mechanisms modulating DSC and their physiological 
implications. In this thesis I present research into both voltage-dependent and -
independent mechanisms mediating modulation of DSC. Within the category of voltage-
dependent effects on DSC, I show ground-breaking research unlinking depolarization-
induced neuropeptide release from calcium influx through voltage-gated calcium 
channels (VGCC) in presynaptic structures.  Furthermore, I show that changes in voltage 
can relieve G-protein mediated inhibition of VGCC through κ-opioid receptor activation 
that has important implications on activity-dependent modulation in vivo. Voltage-
independent interactions mediating modulation of DSC include VGCC inhibition via μ-
opioid receptor activation. This voltage-independent signaling pathway involves release 
of calcium from ryanodine-sensitive intraterminal stores. It is the first time, to my 
knowledge, that a physiological role has been determined for these recently 
characterized, ryanodine-sensitive calcium stores in isolated HNS terminals. 
The historical cornerstone of DSC was established from early research done on 
the neuromuscular junction (Katz and Miledi, 1965b, a; Miledi, 1973; Smith and 
Augustine, 1988). It was here where the calcium hypothesis gained its foothold and from 
where it has only recently been challenged. The calcium hypothesis states that electrical 
stimulation opens VGCC, triggering calcium influx from the extracellular space into the 
cytoplasm. This initiates key steps in vesicular exocytosis and release of vesicular 
content. The main point of the calcium hypothesis is that calcium is the key component 
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for initiation and termination of neurotransmitter release. While most current scientific 
research is based on this premise, recent evidence has introduced the possibility of 
neurotransmitter release being both calcium- and voltage-dependent (Parnas and Parnas, 
1986; Hochner et al., 1989; Parnas et al., 1991). Proponents of the Ca2+-voltage 
hypothesis state that not only is Ca2+ required, but membrane potential as such also plays 
a pivotal role in promoting depolarization-induced release (Parnas and Parnas, 2002). A 
depolarizing stimulus relieves a tonic inhibition of the exocytotic machinery by an 
autoinhibitory receptor. This hypothesis emerged mainly to explain the differences in the 
time course of release in the presence of [Ca2+]o where release is quickly terminated after 
depolarization despite residual high [Ca2+]i (Hochner 1989, Barrett 1979, Matzner 1988, 
Parnas 1989, Datyner, 1980, Andreu 1989). Interestingly the kinetics of extracellular 
calcium-independent release in HNS terminals are reminiscent of the latter part of release 
in the presence of extracellular calcium suggesting a biphasic response to depolarization 
(Brethes et al., 1987; Muschol and Salzberg, 2000). First an extracellular calcium-
dependent response, which leads to a peak of release is followed by a rapid decay. 
Second, a new baseline release in the continued presence of High K+ is established, 
which is independent of extracellular calcium. This second phase of sustained release 
best mimics intraterminal calcium dynamics in the presence of a sustained depolarization 
(Lindau et al., 1992; Stuenkel and Nordmann, 1993a). The existence of voltage- and 
ryanodine-sensitive calcium stores in isolated HNS terminals seemed like a potential link 
between the calcium requirement for exocytosis and voltage during High K+-induced 
release in 0 mM [Ca2+]o. Therefore, unlike the Ca2+-voltage hypothesis, I attempted to 
explain persistent depolarization-induced changes in both capacitance and neuropeptide 
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release in the absence of calcium influx through VGCC coincident with changes in 
[Ca2+]i.  
While my experiments showed that extracellular calcium is not necessary for 
depolarization-induced neuropeptide release, it was clear that ryanodine- and voltage-
sensitive internal calcium stores were not involved in eliciting such release, either. 
However, intraterminal calcium appears to play a role, but it is unclear what, if any, 
calcium stores are involved. Previously I introduced the possibility of calcium being 
released from IP3 stores known to elicit release in isolated terminals (See Chapter III – 
discussion; Fig. 5.2). While this may help explain the intraterminal calcium-dependent 
portion of the depolarization-induced release of neuropeptide in 0 mM [Ca2+]o from HNS 
terminals, a calcium-independent component remains. Interestingly, there is another step 
in the evolution of the calcium hypothesis known as the calcium-independent yet voltage-
dependent release proposed by Zhang and Zhou (2002). Their research shows persistent 
depolarization-induced changes in capacitance in the absence of extracellular or 
intracellular calcium from DRG neuronal somata. These results indicate the existence of 
Ca2+-independent but voltage-dependent vesicular secretion (CIVDS) which may be 
present in HNS terminals.  
The molecular mechanism underlying CIVDS is unknown. Zhang and Zhou 
(2002), speculate about the existence of an intrinsic plasma membrane protein capable of 
sensing the changes in transmembrane potential and responding with a conformational 
change that facilitates exocytosis of the docked vesicles in a Ca2+-independent manner. In 
fact, in pancreatic beta-cells voltage-driven conformational changes that engage the 
ion/EEEE interface of the L-type Ca2+ channel are relayed to the exocytotic machinery 
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prior to ion influx, allowing for a fast and tightly regulated process of release independent 
of Ca2+ influx or release of Ca2+ from intracellular stores (Wiser et al., 1999; Brown et 
al., 2000b; Trus et al., 2007). Therefore, given the CIVD component of depolarization-
induced ECIR in HNS terminals, future experiments will explore the connection between 
VGCCs and proteins directly linked to the exocytotic machinery.  
Alternatively, depolarization has been shown to cause changes in membrane 
tonicity (Kim et al., 2007) similar to those observed during osmotic challenges in which 
the cell or terminal swells or shrinks to accommodate changes in water flow due to 
variations in the osmotic gradient (Ishikawa et al., 1982; Cazalis et al., 1987c; Back et al., 
2000; Hussy et al., 2001). The Neurohypophysis is exquisitely tuned to such changes as 
would be predicted from vasopressin’s critical role in systemic fluid homeostasis. In HNS 
terminals hypo-osmotic challenges induce release of both vasopressin and oxytocin 
(Bacova et al., 2006). Interestingly, the kinetics of the CIVDS are not unlike calcium-
independent hypo-osmotic-induced release. Therefore, we should not underestimate the 
possibility that changes in membrane tonicity or sodium influx due to either higher 
concentrations of extraterminal potassium, such as those seen during High K+ 
stimulation, or electrical stimulation, observed during capacitance and calcium current 
recordings, may converge on sensitive osmotic regulatory mechanisms in the HNS 
underlying release.  
Membrane tonicity may not be an important factor during calcium-dependent 
neuropeptide release, given that permeablized terminals still show transient vasopressin 
secretory responses to manipulations in [Ca2+]o (Stuenkel and Nordmann, 1993a). 
However, also in permeablized terminals, addition of Na+ in the absence of Ca2+ gives 
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rise to increases in vasopressin secretion (Stuenkel and Nordmann, 1993b). Therefore, 
influx of sodium due to depolarization may contribute to neuropeptide release in the 
absence of extracellular calcium. However, it is yet to be determined if intact terminals 
may have mechanically-sensitive triggers for neuropeptide release responding to changes 
in membrane tonicity due to depolarization in the absence of [Ca2+]o.  Interestingly, there 
is a clear physiological equivalent to the High K+ in 0 mM [Ca2+]o conditions under 
which I have tested these isolated terminals. During a physiological burst, action 
potentials are translated into very high frequency stimulations due to the accumulation of 
extraterminal potassium in the interstitial space, while at the same time calcium is being 
depleted (Marrero and Lemos, 2005). Therefore, extraterminal calcium-independent yet 
voltage-dependent release of neuropeptide may serve to extend release, past the 
biophysical limits of VGCC, under the continued demands of high levels of 
physiologically relevant electrical activity. 
If ryanodine- and voltage-sensitive calcium stores in HNS terminals are not 
involved in extracellular Ca2+-independent depolarization-induced release, the question 
persists; do they serve a role during DSC? Amperometric studies have demonstrated no 
correlation between syntillas and quantal release. However, agonist concentrations of 
ryanodine show significant increases in the rate of spontaneous amperometric events, and 
inhibitory concentrations of ryanodine cause the opposite effect (McNally et. al, 2007). 
AVP and OT release from isolated terminals significantly increase in response to 
ryanodine receptor agonists (Velazquez-Marrero et. al., in preparation; See Chapter II), in 
both the absence and presence of [Ca2+]o. These data suggest that spontaneous syntillas, 
may release Ca2+ into cytosolic microdomains not associated with docked, primed 
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vesicles (Berridge, 2006; Oheim et al., 2006; ZhuGe et al., 2006). However, lack of 
coincident release of neuropeptide with syntilla events does not preclude the possibility 
that release of calcium from intraterminal stores may indirectly modulate DSC by 
increasing the probability of exocytosis from a larger readily-releasable pool of granules 
(Fig. 5.2). In HNS terminals, intraterminal calcium stores can prime vesicles for activity-
dependent neuropeptide release (Ludwig et al., 2002; Ludwig and Leng, 2006). 
Furthermore, application of either antagonist concentrations of ryanodine, or the 
competitive ryanodine receptor antagonist, 8-Br cADPR, significantly inhibit both 
depolarization-induced release of OT and its coincident rise in [Ca2+]i (Jin et al., 2007). I 
have carried out experiments measuring AVP release in response to 50 mM High K+-
induced release, which show a reproducible potentiation of the High K+-induced release 
in the presence of 20 mM Caffeine in 2.2 mM [Ca2+]o. This potentiation does not occur in 
the absence of [Ca2+]o, suggesting that calcium influx though VGCC during DSC is a 
necessary prerequisite for “syntilla” modulation of DSC. The evidence therefore suggests 
that CICR likely plays an important role in the amplification of the DSC response as it 
does in other systems (Usachev and Thayer, 1997; Kang and Holz, 2003).  
 As previously mentioned, recent studies targeting oxytocin release in isolated 
terminals of the Neurohypophysis using CD38 knockout mice, clearly shows inhibition of 
depolarization-induced OT release in CD38(-) mice, and in wild-type mice when treated 
with antagonists of the ryanodine receptor or the cADPr pathway (Higashida et al., 2007; 
Jin et al., 2007). I found similar results by calcium imaging with High K+-induced [Ca2+]i 
rise. In seeming contradiction, release of intraterminal Ca2+ from ryanodine-sensitive 
stores during application of the μ-receptor agonist leads to inhibition of VGCC and of 
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subsequent High K+-induced neuropeptide release (Velazquez-Marrero et.al, in 
preparation; See Chapter IV). However, studies show that micro-domains of calcium can 
affect specific targets via select signaling pathways. Graded activation of the ryanodine 
cADPr pathway can encompass a range of physiological responses in combination with 
activation via depolarization. Treating isolated terminals with 8-Br cADPR, a competitive 
antagonist of the ryanodine receptor, at a concentration of 100 μM significantly decreases 
both OT release and the High K+-induced rise in [Ca2+]I (Jin et al., 2007). However, a 
concentration of 100 nM does not affect either, yet effectively targets μ-opioid inhibition 
(Velazquez-Marrero et.al, in preparation; See Chapter IV). The concentration dependent 
effect of 8-Br cADPr on DSC suggests changes in cADPr and subsequent baseline [Ca2+]i 
in terminals has a biphasic effect on DSC (see Fig. 5.2). A similar phenomenon was 
observed in Xenopus oocyte nerve growth cones which respond to a known 
chemoattractant guidance cue with opposite turning behavior, depending on the level of 
cytosolic cAMP and [Ca2+]i (Ming et al., 1997; Hopker et al., 1999). Furthermore, brief 
periods of electrical stimulation of cultured Xenopus spinal neurons resulted in a marked 
alteration in the chemoattractive turning responses of the growth cone, suggesting 
depolarization may also modulate cAMP concentrations and/or [Ca2+]i (Ming et al., 
2001). Therefore, given that HNS ryanodine-sensitive calcium stores are likely Ca2+- and 
voltage-sensitive, specific holding potentials and baseline [Ca2+]i concentrations should 
be taken into consideration when interpreting their effects on both basal and stimulus-
evoked release. 
Our hypothesis states that release of calcium from ryanodine-sensitive stores leads 
to VGCC inhibition presumably via calcium-dependent inactivation (Fig. 5.1). The μ-
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opioid receptor seems to preferentially inhibit OT release by its strong inhibition of the 
R-type calcium channel (Fig. 1.6), where 79% of the isolated R-type currents was 
blocked by DAMGO (Ortiz-Miranda et al., 2005). However, it inhibits L-type by only 
15% and, N-type by 17% in OT terminals (Ortiz-Miranda et al., 2006). Research on 
calcium-dependent inactivation of the R-type calcium channel indicates there are 
hallmark Ca2+-dependent calmodulin interacting domains in the cytoplasmic loops of the 
channel indicating the possibility for calcium-dependent modulation of the channel (Pate 
et al., 2000; Liang et al., 2003). Experiments measuring inactivation rate constants of 
total channel currents in isolated HNS terminals showed slower inactivation with Ba2+ as 
compared with Ca2+ as the charge carrier for total channel currents (Wang et al., 1999b), 
indicating VGCC of HNS terminals do inactivate in a calcium-dependent manner. 
However, the isolated R-type current showed no difference in inactivation with either 
Ba2+ or Ca2+ (Wang et al., 1999b). This seemed to suggest there is no calcium-dependent 
inactivation of the R-type calcium channel in HNS terminals. Nevertheless, it is 
important to note that Ba2+ can bind to the inactivation site of certain VGCC channels, 
giving rise to Ba2+-dependent inactivation (Ferreira et al., 1997) and thus occluding any 
differences in inactivation during Ba2+ substitution. Future experiments should include 
intraterminal calcium buffering with Bapta to best address the possibility of calcium-
dependent inactivation.  
While the possibility for calcium-dependent inactivation of the R-type channel in 
the HNS may be debatable, other VGCC targeted by μ-opioid inhibition show significant 
calcium-dependent inactivation (Branchaw et al., 1997; Wang et al., 1999b). This may 
indicate that either the R-type channel is sensitive to calcium-dependent modulation (still 
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present during Ba2+ substitution as Ba2+-dependent inactivation) or AVP terminals, which 
lack R-type VGCCs, are being preferentially selected. However, significant differences in 
the rates of inactivation of calcium currents during μ-opioid inhibition support the 
involvement of a calcium-dependent process mediating inhibition. As stated in Chapter 
IV, inactivation rates decrease in μ-opioid-treated calcium currents. While these results 
are somewhat unexpected, they are consistent with previous research characterizing 
calcium-dependent VGCC inactivation in HNS isolated terminals. It is interesting to note 
that, unlike other systems, in isolated HNS terminals the time constants for calcium 
current inactivation are faster with Ba2+ substitution and intracellular Bapta when 
compared with Ca2+ (Branchaw et al., 1997). This is the opposite of what would be 
expected for calcium-dependent inactivation of VGCC. To explain these results, 
Branchaw et al. (1997), proposed a simple two-state VGCC model, where open and 
inactivated states are governed by a forward rate when the channel moves from open to 
inactive and a reverse rate when the channel moves from inactive to open. Ca2+ is 
hypothesized to inhibit both the forward and reverse rates, with a greater effect on the 
reverse rate.  
In this thesis, I show that inhibition of VGCC via μ-opioid agonist reduces the 
rate of inactivation, as expected for Ca2+-dependent inhibition where calcium’s net effect 
is increasing the rate at which inactive channels transition into an open state.  While this 
would predict facilitation of calcium influx through the channel it does not take into 
consideration other hallmarks, not yet tested during μ-opioid inhibition, of calcium-
dependent inactivation of VGCC in HNS such as Ca2+-dependent inhibition of recovery 
from inactivation, and the hallmark U-shape of a steady-state inactivation curve 
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(Branchaw et al., 1997). A simpler explanation for the slower inactivation rates in μ-
opioid treated calcium currents takes into account that calcium-dependent inactivation 
can be saturated during release of calcium from ryanodine-sensitive stores. Therefore, 
rate constants during stimulated release would lack the calcium-dependent component of 
inactivation typically elicited via calcium influx and thus seem slower than control 
currents.  
From the research and results presented in this thesis a working hypothesis 
emerges.  Action potentials reach the Neurohypophysis initiating important electrical and 
biochemical events that at different points overlap to ensure optimum efficiency of 
neuropeptide release. Once membrane potential at the terminals reaches threshold, 
initiation of APs triggers VGCC opening which allow extracellular calcium influx. These 
events trigger release of both AVP, with co-release of Dynorphin A, and OT, with co-
release of Met-Enkephalin (see Fig. 1.6). This initiates autocrine and paracrine activation 
of both the κ- and μ-opioid receptors and their respective G-protein signaling pathways. 
The κ-opioid signaling pathway catalyzes the association of the Gβγ subunits of the G-
protein coupled receptor with cytoplasmic components of VGCC triggering slower 
channel opening and consequently calcium influx (Fig. 5.1). Upon high frequency 
stimulation from the soma, activity-dependent relief of κ-opioid inhibition occurs in 
nerve terminals. Met-Enkephalin co-released from HNS terminals triggers activation of 
the μ-opioid receptor which initiates a slower response, at lower concentrations inhibiting 
OT release first. With eventual μ-opioid agonist accumulation, higher concentrations also 
target AVP release. G-protein activation initiates a diffusible second-messenger cascade, 
which is both slower than a membrane-delimited pathway and voltage-independent, 
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triggering activation of ADP-ribosyl cyclase/CD38, which synthesizes cADPr from beta-
NAD+ (Higashida et al., 2007)(Fig. 5.1 & 5.2). Cyclic ADPr then either activates or 
modulates ryanodine receptors in large dense core vesicles. This triggers subsequent 
release of calcium from ryanodine-sensitive stores followed by calcium-dependent 
inactivation of VGCC and possibly calcium-dependent activation of BK channels. 
Termination of this signaling pathway may occur by negative feedback triggered by high 
cADPr concentrations, μ-opioid receptor desensitization, and/or μ-opioid receptor 
internalization.  
In summary, with increasing frequency of electrical activity (i.e., bursts) from the 
soma, κ-opioid receptor inhibition in the terminals is attenuated and μ-opioid agonists, 
co-released with neuropeptide, accumulate in the terminal interstitial space prior to 
diffusion into the adjacent capillary bed or degradation. Subsequent changes in ionic 
concentrations in the terminal interstitial space may then trigger extracellular calcium-
independent yet voltage-dependent release of neuropeptide towards the latter phase of the 
burst. During inter-burst intervals, both μ- and κ-opioid agonist accumulation either 
diffuses away or are broken-down in the interstitial space surrounding the terminals. The 
rate of opioid dispersal and/or degradation may dictate whether subsequent stimulation 
will elicit optimum neuropeptide release. While autoinhibitory effects of co-secreted κ-
opioid agonists have been observed in the somatodendritic region (Brown et al., 2007), in 
HNS terminals I have now demonstrated the capacity for physiologically relevant 
activity-dependent relief. This represents an interesting adaptation serving the unique 
function of the terminals in the magnocellular neurosecretory system. In contrast, the 
slower, voltage-insensitive mechanism mediating μ-opioid inhibition in HNS terminals is 
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best suited for its primary role during gestation. It is during this stage that μ-opioid 
inhibition of OT release progressively increases throughout pregnancy, allowing for OT 
accumulation and OT receptor sensitization. This inhibition is interrupted during 
parturition and later during lactation where OT release from the Neurohypophysis plays a 
critical role in milk letdown. Therefore, integration of both voltage-dependent and –
independent modulatory inputs at the HNS terminals serves to fine-tune the response to 
physiologically relevant input and facilitate optimum depolarization-secretion coupling.  
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Figure 5.1 
 
 
 
 
 
 Figure 5.1 Model for Opioid modulation of VGCC. Activation of the 
κ-opioid receptor initiates Gα-protein dissociation from Gβγ subunits. Gβγ 
mediates membrane-delimited voltage-dependent inhibition of VGCC via 
direct interaction with the channel. Activation of the μ-opioid receptor 
initiates cADPR signaling, presumable via activation of ADP-rybosyl 
cyclase/CD38 complex catalyzing the conversion of NAD+ into cADPr. 
Cyclic ADPr subsequently leads to activation/modulation of ryanodine 
receptors on neurosecretory granules (NSG) in the terminals. Release of 
Ca2+ from ryanodine-sensitive stores subsequently results in Ca2+-
dependet inactivation of voltage-gated calcium channels. Figure modified 
from Lemos, 2002.  
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Figure 5.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Intraterminal Ca2+ regulation of neuropeptide release in HNS terminals. A. μ-opioid 
agonist binds to its receptor initiating a diffusible second-messenger cascade resulting in cADPr-induced 
release of Ca2+ from ryanodine-sensitive stores. Calcium release leads to calcium-induced inactivation 
(CDI) of voltage-gated calcium channels (VGCC). Inactivation of VGCC inhibits Ca2+ influx and 
subsequent depolarization-induced release. B. In the absence of Ca2+ influx through VGCC, depolarization 
mobilizes intraterminal Ca2+ from an unknown source, possibly IP3 stores, eliciting neuropeptide release in 
a extracellular Ca2+-independent manner. C. During depolarization, VGCC allows influx of Ca2+ from the 
extracellular space resulting in activation of ryanodine-sensitive stores via calcium-induced calcium release 
(CICR) and subsequent mobilization of granules from the releasable pool (RP) to the readily releasable 
pool (RRP) amplifying the DSC response. Figure inspired by Leng et al.(2002). 
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